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This dissertation is an analysis of skeletal muscle atrophy and a molecular 
assessment of potential preventative treatments. Chapter I begins with a background of 
skeletal muscle atrophy along with an analysis of associated molecular pathways. Here, 
we discuss how skeletal muscle atrophy is the consequence of protein degradation 
exceeding protein synthesis and can occur when a muscle is abnormally disused. The 
development of therapies prior to skeletal muscle atrophy settings to diminish protein 
degradation is scarce and could be useful to prevent negative clinical outcomes of 
patients who must unload and disuse musculature over extended periods. Mitochondrial 
dysfunction is associated with skeletal muscle atrophy and contributes to the induction of 
protein degradation and cell apoptosis through increased levels of ROS. This damages 
mtDNA, leading to its degradation and mutation resulting in dysfunctional mitochondria. 
Mitochondrial transcription factor A (TFAM) protects mtDNA from ROS and 
degradation while increasing mitochondrial function and the transcription of 
mitochondrial proteins. Exercise stimulates mitochondrial function by activating cell 
signaling pathways that converge on and increase PGC-1α, a well-known activator of the 





exercise training prior to muscle unloading and disuse will prevent skeletal muscle 
atrophy. Additionally, we hypothesize this protective effect of exercise in preventing 
skeletal muscle atrophy is associated with increased mitochondrial markers. In Chapter 
II, we test these hypotheses by first inducing skeletal muscle atrophy using hindlimb 
suspension (HLS) and exercising mice prior to this suspension. The results indicated 
exercising prior to HLS reduced many of the morphological and molecular changes 
within the muscle associated with atrophy. Also in Chapter II, we follow up these 
findings through mitochondrial molecular analyses with results showing exercise 
increasing mitochondrial-associated markers and redox balance. We also find decreases 
in TFAM after HLS, which led to further analyses through the use of a TFAM 
overexpression transgenic mouse model in HLS. We reason if HLS induces excessive 
ROS accumulation and decreases TFAM, overexpressing this gene may prevent 
mitochondrial dysfunction mechanisms associated with atrophy. Therefore, we 
hypothesize the overexpression of TFAM diminishes skeletal muscle atrophy and, 
secondarily, TFAM overexpression combined with exercise training will synergistically 
prevent atrophy caused by HLS. To assess these hypotheses, in Chapter III we subject 
TFAM mice to HLS as well as exercising TFAM mice prior to entering HLS. Results 
here reveal TFAM overexpression diminishes skeletal muscle atrophy caused by HLS 
and combining exercise and TFAM overexpression resulted in no significant difference 
compared to exercising prior to HLS in wild-type mice. Collectively, the data indicate an 
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Skeletal Muscle Atrophy 
Skeletal muscle serves many important functions affecting the human physiologic 
state. Standard perception of the function of skeletal muscle is generally in propulsion for 
locomotion and desired movement, such as the musculature of the upper legs contracting 
and relaxing to extend and retract the lower leg at the knee joint repetitiously as part of 
the coordination of walking. However, this tissue also serves as an important amino acid 
and glucose reservoir and is the largest metabolically active organ in the human body 
(117). Pathological loss of this tissue, known as skeletal muscle atrophy, is associated 
with numerous health abnormalities and can greatly affect quality of life. 
Skeletal muscle atrophy is caused by a host of factors including disease, ageing, 
injury, nutritional decrements, and disuse. It is characterized by a decrease in the cross-
sectional area of the muscle, a decline in force generative capabilities, decreases in 
functional proteins of the muscle mass, and a loss of oxidative ability making the tissue 
less resistant to fatigue (140). The scope of the present dissertation project will focus on 





The abnormal disuse of muscle occurs for many reasons including bed rest from 
disease or injury, cast immobilization due to injury, spinal cord injury, weightlessness 
environments, and a sedentary lifestyle. Ultimately, reduced muscle contraction and 
mechanical stress from a lack of loading stimuli on the muscle encompasses disuse. 
When this happens, increased activation of protein signaling pathways leading to protein 
degradation and apoptosis arise with corresponding downregulation of protein synthesis 
pathways (140). This imbalance is depicted in Figure 2. 
Skeletal muscle atrophy can be gravely debilitating and is associated with 
increased morbidity and mortality (113). One can imagine a scenario in which a patient is 
prescribed bedrest for an extended time, due to injury, and accumulates significant 
muscle atrophy which renders this person incapable of performing basic physical tasks, 
such as simply rising out of bed. Diminished force production from atrophic muscles is 
associated with the onset of fatigue and a potential, further reduction in physical ability. 
Not only is the patient’s quality of life harshly diminished, healthcare costs in the form of 
medications and rehabilitation sharply increase to attempt to combat this condition. 
Therefore, it is important, both medically and fiscally, to study interventions that may 
potentially prevent atrophy.  
There is a clear link in the literature with skeletal muscle atrophy to the 
dysfunction of the mitochondria (69, 96) and redox imbalance (114) to the induction of 
degradation and apoptotic pathways, which results in the physical reduction of the tissue. 
The study of these molecular mechanisms associated with atrophy is warranted to 






Figure 1. Molecular scale of atrophy. Scale representation of the molecular imbalance 
of skeletal muscle atrophy. Degradation and apoptosis exceeding protein synthesis results 





































therapies of the future. To be able to do this, we must have a clear understanding of what 
causes atrophy to lead to how we can prevent the condition. 
 
Protein degradation. Disuse-induced muscle atrophy has many causes, as previously 
stated. While the causes occur from different scenarios, they all similarly reduce 
mechanical stress and fiber contraction in the muscle. The mechanical stress of 
contracting skeletal muscle under a physical load in a healthy individual causes many 
changes throughout skeletal myocytes. Contraction induced by myosin and actin cross-
bridging is sensed by the cell via proteins such as dystrophin and integrin complexes (5). 
Dystrophin is a cytoplasmic protein that interacts, on one end, with actin fibers under the 
cell surface and, on the opposite end, associates with membrane-bound proteins that form 
a dystrophin complex spanning the entire sarcolemmal membrane (40). During actin and 
myosin contraction, lateral force production is created in the myofilaments. Anchoring 
proteins, such as dystrophin and the associated complex, turn this lateral force into linear 
force to disperse across the sarcolemma. Through adhesion molecules, such as laminin, 
this linear force is converted back into lateral force as it transmits through the 
sarcolemma and into the extracellular matrix throughout the muscle. This acts as a “shock 
absorber” and provides stiffness to the contracting myocyte and prevents the initial lateral 
force of the myofilaments from being transferred into the sarcolemma inappropriately, 
causing deformation of the membrane.  
Pasternak’s group demonstrated this by using dystrophin knockout (mdx) mice 
lacking this protein (similar to humans with Duchenne muscular dystrophy). Mdx mice 





(108). This important protein and its respective complex, along with other sensory 
complexes (integrin), activates focal adhesion kinases (FAKs) and mediates the 
prevention of apoptosis and activation of growth pathways (5). With unloading and 
disuse, mechanical stress is greatly reduced and the corresponding growth signaling and 
apoptosis prevention is prohibited. Further, lack of contraction leads to the activation of 
catabolic pathways in skeletal muscle.  
The ubiquitin-proteasome pathway is a main regulator of protein degradation. 
Muscle ring finger-1 (Murf-1) and Atrogin-1/MAFbx are E3 ligases in skeletal muscle 
that play a key role in ubiquitin marked degradation (45). These ligases are activated by 
multiple stimuli, in particular ROS, inflammatory markers, and the unloading of muscle. 
Activation of IκB kinase (IKK) occurs via these stimuli, which is associated with the 
activation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) (11). 
NF-κB is a transcription factor responsible for transcription of many degradative genes. 
In this case, NF-κB is able to translocate into the nucleus and play a role in the 
transcription of Murf-1 and Atrogin-1/MAFbx. Mature Murf-1 and Atrogin-1/MAFbx 
proteins polyubiquinate polypeptides in the muscle as a method of targeting the protein 
for degradation. Skeletal muscles consist mostly of the myofibrillar proteins myosin and 
actin involved in the functional aspect of the cells. Therefore, for significant atrophy to 
occur, these proteins must be degraded.  
Murf-1 is involved in targeting myosin light chains for degradation while atrogin-
1/MAFbx targets actin molecules (9). After these myofibrillar proteins are 
polyubiquinated, proteasomes attach and degrade the protein resulting in atrophy. Tawa 





activity in the rat soleus muscle of three atrophy inducing pathological states 
(denervation, hyperthyroidism, sepsis). Without altering protein synthesis expression, 
protein balance increased with high percentages of reductions in proteolysis and an 
increase in ubiquinated proteins of the muscle was observed (139). This study, among 
others, delineated the ubiquitin-proteasome pathway as the key modulator of protein 
degradation and thus, should be considered when working with skeletal muscle atrophy 
models. It is possible that different pathways contribute to degradation in different 
settings based upon the conditions of the model and should also be considered when 
reviewing data. 
Other protease contributors in skeletal muscle protein degradation include 
calpains and lysosomes (16). Calpains are intracellular proteases that are regulated by 
Ca2+. In skeletal muscle, calpain-1, calpain-2, and calpain-3 are mainly expressed. 
Calpain-3 is downregulated during atrophy as well as in exercise suggesting that its 
absence is necessary for atrophy (4). Recently, Shenkman and colleagues used an 
inhibiting agent to diminish calpain-1 in a rat model while inducing skeletal muscle 
atrophy by hindlimb suspension for 3 days. The soleus muscle size was significantly 
reduced in rats that were only suspended while those suspended and treated with the 
calpain-1 inhibitor retained muscle size (126).  Calpain-1 levels were increased in the 
suspension only model. Interestingly, levels of calpain-2 were not affected by hindlimb 
suspension induced atrophy, indicating a key role of calpain-1 in short-term (3 days) 
disuse. Inhibiting calpain-1 decreases MAFbx expression and inhibits protein 
ubiquitination. Studies increasing the atrophy duration should be done to further elucidate 





Lysosomal activity is also a contributing factor to protein degradation in muscle. 
Autophagy using lysosomal machinery (autophagy-lysosomal system) is upregulated 
during catabolic states of skeletal muscle (120). Normal contraction of muscle tissue over 
time causes damage to the contracting proteins as well as organelles of the cell. For these 
damaged proteins and organelles to be degraded and recycled to continue normal or 
enhanced function, the cells must have a self-selecting degradative system. This system is 
autophagy.  
Again, NF-κB pathway is an important transcription factor inducing autophagy. 
Autophagosomes consume defective proteins of the cell and transport the defective 
material to lysosomes. Lysosomes are membrane-bound vesicles containing acid 
hydrolases that, when released, degrade the cellular components of the autophagosome 
(7). The process is also induced by multiple types of exercise (63, 124). This could be to 
enhance the removal of damaged proteins due to the stress of exercise contractions or 
may also be to provide energy for sustained contractions in the cell. While this process 
positively impacts the function of skeletal muscle tissue, excessive autophagy-lysosomal 
activity, as seen in many myopathies, leads to atrophy. 
 
Cell apoptosis. Cells undergo a programmed cell death (apoptosis) due to specific 
biochemical interactions that cause blebbing of the cell membrane, condensation of 
chromatin, and cell fragment lysis resulting in the death of the cell. When skeletal muscle 
is not contracting over time, as occurs in disuse, an increase in cell apoptosis has been 
observed (130). As load and contractions of the muscle diminish, the removal of 





cellular proteins. The myonuclear domain is reduced, resulting in diminished function in 
the myofiber.  
Caspases are proteases within the cell that play a role in the disassembly of the 
nucleus and cytoskeleton while cleaving many other cellular proteins. Caspases are 
categorized as “initiators” and “executioners” with caspase-2, -6, -9, -10 being 
characterized as initiators while caspase-3, -7, and -8 are executioners (20). Specifically, 
caspase-3 is a major executioner involved in skeletal muscle atrophy. Signaling for 
caspase-3 includes both extrinsic and intrinsic factors. Extrinsic factors include binding 
of the tumor necrosis factor (TNF) ligand to TNF death receptors on transmembrane 
proteins. This TNF binding causes a signal cascade that results in procaspase-8 and the 
activation of the caspase-3 executioner. Capase-3 activates an endonuclease (CAD) that 
degrades DNA (32) and thus, the execution of apoptosis.  
A major intrinsic pathway leading to caspase-3 activation includes the release of 
cytochrome c (Cyt c) from the mitochondria. Signals such as elevated levels of ROS and 
reactive-nitrogen species (RNS) increase mitochondrial membrane permeability that 
release Cyt c from the mitochondria (29). B-cell leukemia/lymphoma 2 (Bcl-2) and Bcl-
XL block the release of Cyt c and serve an anti-apoptotic role. Members of the Bcl-2 
associated death promoter (BAD) family, such as BAX and BAK, serve as pro-apoptotic 
factors and increase pore permeability of the mitochondria allowing the release of Cyt c 
(160). Cyt c is then involved in the activation of the initiator caspase-9, forming an 
apoptosome complex. This leads to the activation of the executioner caspase-3 and 
degradation of cellular components (152). Leeuwenburgh et al. performed hindlimb 





increase in caspase-3 activity in the soleus of young rats after inducing atrophy over 14 
days (83). Furthermore, a study by Nagano and colleagues observed active caspase-3 
activity in male Wistar rats after 3-weeks of hindlimb unloading (98). These studies 
indicate an apoptotic link between disuse-induced muscular atrophy and caspase-3. 
There are caspase-dependent and caspase-independent pathways that induce 
apoptosis. Apoptosis-inducing factor (AIF) is released from the mitochondria upon 
stimulation from pro-apoptotic signals. This AIF activates apoptosis through 
chromosomal condensation and DNA fragmentation in a caspase-independent manner 
(62). EndonucleaseG (EndoG) is a protein released from the mitochondria after pro-
apoptotic signaling. EndoG is caspase-independent and is associated with DNA 
fragmentation that coincides with apoptosis during muscle atrophy induced by hindlimb 
suspension in aged mice (29). With a multitude of cell signaling pathways involved in 
cell apoptosis, cross-talk is likely to occur between the various cascades. 
 
Protein synthesis. The counterbalance to protein degradation in muscle cells is protein 
synthesis. As stated previously, when degradation exceeds synthesis over time, atrophy 
occurs. Signals for protein synthesis include many stimulatory factors such as mechanical 
loading of the muscle, hormone circulation, and nutrition. Conversely, protein synthesis 
signaling is inhibited by fasting, augmentation of growth factor release or binding, and 
muscular disuse. Many proteins play a role in the synthesis pathway but the previously 
mentioned mammalian target of rapamycin (mTOR) is consistently viewed as the major 





Two functional complexes are formed from mTOR termed mTOR complex-1 and 
mTOR complex-2 (mTORC1 and mTORC2). Although both mTORC1 and mTORC2 
have a unique role, both complexes will be encompassed and referenced as ‘mTOR’ for 
the scope of the current review. Signaling from extracellular growth factors, such as IGF-
1 and insulin, and amino acids (specifically branched-chain amino acids) lead to the 
activation of the PI3K/AKT pathway that is associated with the activation of mTOR (80). 
Mechanical loading via resistance exercise of the skeletal muscle also activates this 
pathway to activate mTOR (27, 103).  
Activated mTOR interacts with many downstream effectors including two well-
established proteins in particular, S6 kinase (S6K) ribosomal protein and eukaryotic 
translation initiation factor-4 (eIF-4E) binding protein (4E-BP) (94). The phosphorylation 
of 4E-BP by mTOR allows the unbinding and activation of eIF-4E. Similarly, other eIF-
family proteins are activated with the phosphorylation and activation of S6K by mTOR. 
These signaling cascades increase translation initiation rates and thus, overall protein 
synthesis.  
Speculatively, one could assume during skeletal muscle atrophy the rates of 
protein synthesis would decrease due to the lack of loading stimuli. In this case you could 
also assume you would observe diminished mTOR signaling. However, results from You 
et al. revealed an increase in mTOR activity after 7 days of hind limb immobilization in 
mice (161). Similarly, in a mouse hindlimb unloading model, Liu and colleagues 
observed increased 4E-BP binding and decreased eIF-4E activation (decreased protein 
synthesis) after 3 days and diminished binding and enhanced eIF-4E activation (increased 





mechanism in which protein synthesis signaling is induced to protect or save the muscle 
tissue from wasting after prolonged periods of disuse. Furthermore, as noted previously, 
during muscle atrophy we observe a decline in normal muscle tissue morphology and 
function. With variation in protein synthesis during atrophy, it appears the degradation 
process accompanying muscle disuse and the associated atrophy may outweigh any 
countering protein synthesis that is occurring.  
However, the balance of synthesis and degradation lies at the foundation of the 
muscle cell net protein status. Therefore, the synthesis status of muscle is still a heavily 
weighted component when considering atrophy. For example, when we observe increases 
in AMPK, signaled by reduced cellular ATP levels, the result is an associated 
inactivation of mTOR (110). Speculatively, reduced mitochondrial function results in 
decreased cellular ATP and the activation of AMPK with the inactivation of mTOR. This 
inactivation may further shift the balance of the muscle tissue towards an atrophic state, 
with the mitochondria organelle playing a key role. 
 
Mitochondria and TFAM 
Mitochondria are cellular organelles responsible for the production of energy in 
the form of ATP and are also being analyzed for their role in skeletal muscle health. 
These organelles are believed to be directly descended from pro-bacteria forming an 
endosymbiotic relationship with an original eukaryotic host cell, leading to the self-
replicating nature of mitochondria we observe today (60). As mentioned previously, the 





greatly affected by ROS. These reactive molecules are specifically implicated in the 
abnormal changes of the above pathways during disuse-induced atrophy (102). While 
there are many sources of intracellular ROS, the mitochondria organelles appear to be a 
major source of a specific ROS called superoxide anion. Certain centers in the electron 
transport chain may leak electrons, which can reduce oxygen molecules to form 
superoxide anion (144). The rate at which this leaking of electrons can occur varies 
during acute events as well as a during chronic events. Many pathological states, 
including disuse-atrophy, are correlated with disproportionate superoxide anion 
accumulation leading to excessive oxidative stress (14).  
Excessive ROS will activate degradation and apoptotic pathways and must be 
neutralized by antioxidants to prevent abnormal cellular degradation. In the case of 
superoxide anion, dismutation can occur in the presence of a family of particular 
antioxidants called superoxide dismutases (SODs). SODs will catalyze the reaction of 
superoxide anion to hydrogen peroxide, which can then be further reduced to water in the 
presence of glutathione peroxidase (144). SOD-1 typically catalyzes this reaction in the 
cell cytosol while SOD-2 (also called mtSOD) does this in the mitochondria. The 
presence of increased superoxide anion without the appropriate increase in SOD-2 could 
result in the deleterious effects of oxidative stress in the mitochondria, and may be 
specifically linked to mtDNA.   
 
MtDNA. The maternal genetics create the mitochondrial lineage of most animals (17). 
Upon fertilization, paternal mitochondrial DNA (mtDNA) is selectively degraded by a 





degradation leads to mitochondria from the paternal side being effectively abolished, 
allowing for maternal mtDNA to replicate and normal development of the organism 
(163).  
MtDNA is a double-stranded, circular genome located in the inner mitochondrial 
matrix of the organelle, compartmentally separate from the nuclear DNA of the cell. 
MtDNA is approximately 16.5 kilobases coding for 37 genes. Thirteen of these genes 
encode functional subunits of the electron transport chain which are essential for 
oxidative phosphorylation (OXPHOS) (12, 60). Twenty-two genes encode transfer RNAs 
while 2 genes encode ribosomal RNAs, all of which are involved in the synthesis of 
mitochondrial proteins. The remaining protein of the mitochondria requires nuclear DNA, 
cytosolic translation, and effective import into the organelle.  
MtDNA is essential to maintain energy homeostasis in the organism. Defects in 
mtDNA are associated with a multitude of mitochondrial related diseases and phenotypes 
such as diabetes, cancer, aging, and cardiovascular disease (13, 60, 149)  While many 
diseases may not originate in the mitochondria, there may still be an element of 
mitochondrial dysfunction involved in the disease genesis or progression. Alterations in 
the mitochondrial genome change the morphology and physiology of specific tissues. In 
skeletal muscle, Gehrig et al. observed a fiber-type switching from type I and more 
oxidative muscle fibers towards type II and more glycolytic muscle fibers in humans with 
mitochondrial myopathy (42). This type of mitochondrial defect changes the form and 
function of skeletal muscle leading to variations in the predominant energy sources used, 
increased muscle weakness, and decreased muscle health by a loss of oxidative capacity. 





DNA variants, reactive oxygen species (ROS) interactions, and transcriptional machinery 
defects. The consequence of these issues affects mtDNA copy number availability and 
interrupts typical synthesis of proteins in this organelle (132). In the skeletal muscle of 
aging humans, increases in mtDNA mutations and decreases in mtDNA copy numbers 
has been observed (127) and is typically associated with decreases in muscle mass 
(atrophy) and function. If the synthesis of mitochondrial and OXPHOS proteins is 
disrupted by an abnormality or a decrease in mtDNA copy number, a decrement in the 
efficient production of ATP (147) and the overproduction of ROS occurs. This increase 
in ROS further associates with mtDNA and leads to greater mutation and degradation 
creating a disturbance in energy homeostasis and an increased potential for association 
with disease. Excess ROS is also implicated in the activation of protein degradation and 
apoptosis pathways in muscle through ubiquitin-proteasome and caspase pathways, 
respectively (129, 141). An unbalanced increase in these pathways is highly correlated to 
skeletal muscle atrophy (16) and depicted in Figure 3. Therefore, we conclude 
maintaining the mtDNA structure and mtDNA copy number to transcribe mitochondrial 
proteins are vital components of proper health and function in skeletal muscle.  
 
TFAM. As indicated in the literature, the protein responsible for maintaining properly 
functioning mtDNA is mitochondrial transcription factor A (TFAM) (79). TFAM is a 
diversely operating protein playing a role in mtDNA transcription, organization, and 
maintenance. Lack of this transcription factor in systemic TFAM knockout mice resulted 
in severe mtDNA depletion and embryonic lethality (134). A 2004 study using a 





Figure 2. Disuse leads to atrophy. Flow chart of connecting muscle unloading and 
disuse to net protein loss and atrophy indicating mitochondrial dysfunction and redox 





































and embryonic lethality (134). A 2004 study using a combination of TFAM 
overexpression and knockout mice reveals mtDNA copy numbers are directly 
proportional to TFAM levels (31). Overexpression of TFAM in cardiac myocytes in a 
transgenic mouse model increased mtDNA copy number and diminished pathological 
hypertrophy after myocardial infarction. This subsequently led to an increase in survival 
rate (38). These studies provide evidence in an initial link between TFAM and mtDNA. 
TFAM is a low molecular weight molecule (~25 kDa) with non-specific DNA 
binding properties encoded in the nucleus and transcribed in the cytosol as a pre-protein. 
From here, it is shuttled to the mitochondrion by a complex of cytosolic heat shock 
proteins (HSPs), HSP60 and HSP70, that act as protective chaperones and as a guide to 
locate the mitochondria. HSP protection prevents phosphorylation, promotes proper 
folding, and deters degradation during transport (79). The HSP60/HSP70 complex and 
attached pre-protein then bind to specific cytosolic receptors located on the translocase of 
the outer membrane complex (TOM) of the mitochondria, which serves as a main entry 
point for many mitochondrial proteins (107). The TFAM pre-protein will, next, pass from 
the TOM, through the intermembrane space, to a channel of the translocase of the inner 
membrane (TIM), specifically TIM23, using the selectivity of this complex for positively 
charged molecules (121). Entry into the matrix is achieved first by the binding of a 
mitochondrial heat shock-protein chaperone, mitochondrial HSP70, to TIM23 at a 
specific docking site (TIM44). TIM44-associated HSP70 causes conformational changes 
in HSP70 that either passively traps or actively pulls TFAM to the chaperone, as the 
precise mechanism is not completely understood (122). A mitochondrial processing 





side of TIM, while a chaperone, mtHSP60, along with mtHSP70, will re-fold the protein 
into its mature form inside of the matrix (50). Again, in the inner mitochondrial matrix, 
the mitochondrial heat shock protein complex mtHSP60/mtHSP70 serves as a protector 
of TFAM from degradation. Specifically, the mitochondrial protease, LON, selectively 
degrades oxidatively modified and improperly folded TFAM unbound to mtDNA (89).  
After effective transport into the matrix, properly folded TFAM is able to come into close 
proximity with mtDNA. The process of TFAM import is shown in Figure 4. 
 
TFAM binding: mtDNA transcription initiation and protection. Free mtDNA and free 
TFAM are both rapidly degraded in the matrix. As mentioned previously, mtDNA 
interacting with ROS promotes a decrease in mtDNA copy number and unbound TFAM 
is cleaved by Lon protease. TFAM interacting with mtDNA will form a protein-DNA 
complex known as a mitochondrial nucleoid which prevents the degradation of each 
component (70). This complex forms these nucleoid structures as TFAM binds and coats, 
potentially, the entire mitochondrial genome. This provides the structural stability of the 
mtDNA. Ekstrand et al. revealed that the levels of total TFAM were directly proportional 
to the number of mtDNA copies in a mouse embryo model (31). Further, work done by 
Larsson, et al., revealed that heterozygous TFAM depletion resulted in 35-40% decreases 
in mtDNA copy numbers while homozygous TFAM depletion resulted in embryonic 






Figure 3. TFAM import. Process of mitochondrial import of TFAM. The process begins 
at number “1” in which TFAM mRNA is transcribed from nuclear DNA and ends at 





























provide strong evidence of the correlation of TFAM and mtDNA and supports the role of 
TFAM preventing degradation of mtDNA.  
TFAM will abundantly bind mtDNA both specifically and non-specifically. Two 
distinct promoter regions of mtDNA, light strand promoter (LSP) and heavy strand 
promoter 1 (HSP1), are bound by TFAM while other non-distinct regions of the 
mitochondrial genome are also able to bind. The specific binding of TFAM to these 
promoter regions activates transcription of the genome.  
Specific binding of TFAM upstream of promoter sites induces bending of the 
genome and recruitment of transcriptional machinery. Two high mobility group-box 
domains (HMG-box A and HMG-box B) insert into grooves on the LSP, HSP1, or non-
specific regions of mtDNA. These insertions cause distortion of the mtDNA and result in 
bending (100). Bending allows TFAM to interact with the transcriptional machinery, 
specifically mitochondrial RNA polymerase (POLRMT). POLRMT has sequence 
specific binding to TFAM and mtDNA promoter regions as well as upstream regions. 
This complex encourages binding of mitochondrial transcription factor B2 (TFB2M), 
resulting in a single RNA precursor in the mitochondrion and is the initiation of 
transcription (77). This process further advances to transcription elongation, transcription 
termination, initiation of translation, and translation elongation ultimately resulting in the 
synthesis of mature mitochondrial proteins (138). While the majority of mitochondrial 
proteins are nuclear encoded and require organelle import, intramitochondrial protein 
synthesis is still a highly necessary process to ensure proper function and maintenance of 





Interventions to improve mitochondrial dysfunction and promote normal function 
have been widely studied. Treatments include pharmacologic, nutritional 
supplementation, and exercise prescription. These treatments generally attempt to 
modulate one or more of the various signaling pathways involved in the creation of 
mitochondrial proteins, also termed mitochondrial biogenesis, to counteract dysfunctional 
effects (65, 84, 119). The effects of exercise specifically correlate with an increase in 
transcription factors of the mitochondria in skeletal muscle. A 90-minute bout of 
endurance exercise in mice increased nuclear encoded and mitochondrial encoded genes 
involved in mitochondrial biogenesis including key transcription factors and signaling 
proteins (119). Furthermore, a study inducing contractile activity of the rat tibialis 
anterior muscle by electrical stimulation revealed a significant increase in TFAM, a 
mtDNA regulatory protein. The stimulation increased TFAM mRNA levels after four 
days of stimulation while also increasing mitochondrial TFAM protein levels and 
mitochondrial specific enzymes after 5 days (44). This indicated TFAM expression is 
connected to the creation of new mitochondria with exercise. Thus, this project will 
emphasize the role of exercise in inducing mitochondrial biogenesis pathways associated 




Exercise enhances physical performance and is well known to be associated with 
many positive health benefits (155). A single bout of exercise causes a change in 





duration, frequency, and intensity of contractile activity in muscle tissue occurs from 
physical exercise, specific signaling mechanisms will ensue, leading to the tissue 
adapting to the demand of the physical stress. Levels of circulating inflammatory 
markers, growth factors, and adrenergic compounds also increase during exercise. 
Exercise induces phenotypic changes of the muscle that include increased cross-sectional 
area, increased capillary density, fiber-type transitioning, and mitochondrial biogenesis 
resulting in increased mitochondrial density of the muscle cell (41, 159). This increased 
mitochondrial density is a part of an adaptive process allowing the organism experiencing 
the stress of exercise to increase functional proteins involved in the creation of energy 
(mitochondria and the OXPHOS system) to handle that specific stress in the future. A 
key component of exercise-induced mitochondrial biogenesis occurs via the effects of 
skeletal muscle contraction and the upregulation of TFAM (44). 
For a skeletal muscle to contract, an action potential(s) must propagate from the 
motor cortex, through nerve fibers of the central nervous system, synapse at motor 
neurons located on the spinal cord down to the neuromuscular junction (NMJ). The signal 
must cross the NMJ and further propagate across the sarcolemma of the muscle and down 
into the t-tubules where voltage-gated dihydropyridine receptors (DHPRs) are able to 
interact with ryanodine receptors. Ryanodine receptor activation releases calcium from 
the sarcoplasmic reticulum (SR) into the cytoplasm of the muscle cell (115). From there, 
calcium can bind to troponin and remove tropomyosin from active binding sites of actin 
contractile proteins. Finally, in the presence of adequate ATP, muscle contractions can 
occur by the recycling of cross-bridging between myosin and actin proteins. During 





The release of calcium from the SR as well as the increased demand for ATP in this 
process leads to significant molecular changes within the cell. 
The amount of cytosolic calcium released from the SR in skeletal myocytes 
during contraction not only depends on duration, frequency, and intensity of exercise of 
the muscle but also on the muscle fiber type. Isolated single muscle fiber calcium has 
been measured previously to be concentrated in the range of 30-50 nM. Upon 
stimulation, type I (slow-twitch) muscle fibers produced concentrations between 100-300 
nM of calcium while type II fibers (fast-twitch) are capable of a drastically higher (~10x) 
1-2 µM range (43). Baylor and colleagues report fast-twitch fibers capable of 3-4 times 
the amount of slow twitch (6). Nonetheless, cytoplasmic calcium concentrations in 
contracting fast-twitch muscle appear to be much greater than slow-twitch. This is 
important because specific types of exercise requiring higher relative intensities and 
perhaps longer relative durations recruit type II fibers at a greater rate than lower 
intensity exercise and disuse of the muscle (76). This leads to high levels of cytosolic 
calcium and increased intracellular signaling. Specifically, increased calcium activates 
calcium/calmodulin-dependent protein kinases (CAMKs) that are linked to increases in 
mitochondrial biogenesis (15, 19).  
Increasing the intensity of physical activity also increases the AMP/ATP ratio in 
skeletal muscle (74, 153). As the previously described contraction process takes place 
and the cellular energy demand increases, the use of phosphate groups from ATP 
increases the amount of ADP and AMP, thus increasing the AMP/ATP ratio. AMP 
interacts with an AMP-activated protein kinase (AMPK) that is interrupted by high levels 





inhibits the activation of AMPK (90). Exercise not only increases the AMP/ATP ratio but 
also depletes muscle glycogen, potentially releasing and activating AMPK. For these 
reasons AMPK is a cellular energy sensor and has been characterized as a “master 
switch” of metabolism (59). In response to exercise, activation of AMPK leads to 
downstream activators of mitochondrial biogenesis (8, 125).  
Exercise will also acutely increase the levels of ROS in muscle (25). ROS has 
been implicated in many health disorders including muscle myopathies (95). The major 
contributors to ROS in skeletal muscle include xanthine oxidase (XO), NADPH-oxidases 
(NOXs), and mitochondria. In mitochondria, ROS production occurs due to electron 
leakage in the electron transport chain (ETC) (47). The ETC passes electrons through a 
series of protein complexes along the inner mitochondrial membrane with oxygen being 
the last acceptor of the electron. As oxygen accepts electrons in the ETC, it typically 
results in the formation of water. Oxygen that undergoes incomplete reductive processes 
results in radicals and the potential formation of ROS. Complex I and Complex III of the 
ETC appear to be the greatest contributors of ROS in the mitochondria. Although the 
precise contributions of each is poorly understood, these locations in muscle cells 
produce oxidants that are capable of negatively affecting cellular function while also 
activating potentially beneficial signaling pathways. An example of this was 
demonstrated in which male Wistar rat groups performed exercise and ate high 
antioxidant diets. The groups eating high antioxidant diets revealed decreased levels of 
mitochondrial biogenesis markers, regardless of exercise, indicating a potentially 
negative outcome of decreasing ROS signaling (135). The maintenance and balance of 





important factors in skeletal muscle health and control potential mitochondrial biogenesis 
signaling. 
Other major signaling mechanisms of exercise and mitochondrial biogenesis 
include the increased levels of inflammatory markers, epinephrine, and growth factors. 
Markers such as interleukins (IL-1,6) and tumor necrosis factor-alpha (TNF-α) bind 
cellular receptors and lead to increases in ROS production (73). Adrenal glands release 
epinephrine in response to exercise. Speculatively, this could be because of both the 
physical stress that is perceived as well as an emotional response that potentially occur 
during more intense forms of exercise, causing the release of epinephrine. Binding of 
epinephrine to β-adrenergic receptors of the cell lead to increases in cyclic AMP (cAMP), 
involved in biogenesis pathways. Growth factors such as insulin-like growth factor-1 
(IGF-1) and insulin enter the cell and activate protein synthesis pathways, also implicated 
in the creation of mitochondrial proteins (93).  
 
Exercise and TFAM connection. The various effects of skeletal muscle contraction and 
the stress of exercise connect to mitochondrial biogenesis in several ways. These 
upstream signals converge downstream to ultimately increase TFAM transcription. This 
convergence point is a major link of exercise to mitochondrial biogenesis and has 
received a great deal of attention in the literature and is known as the peroxisome 
proliferator-activated receptor-gamma coactivator 1-alpha (PGC-1α) and is activated in a 





PGC-1α is a transcriptional coactivator with formidable evidence of its correlation 
to exercise. Endurance exercise increases levels of PGC-1α in rat soleus muscle 18 hours 
post-exercise (137). Kang et al. subjected female Sprague-Dawley rats to anaerobic 
sprinting exercise and noticed a 5.6-fold increase in PGC-1α in the exercise group 
compared to the controls (68). Another group subjected rats to 20 minutes of aerobic 
treadmill running and increased PGC-1α mRNA levels 1.5-5 fold in soleus and 
gastrocnemius muscles while also noting 6 weeks of chronic exercise increased PGC-1α 
mRNA levels by ~25% in rat soleus muscle (10).  
The aforementioned increase in cytosolic calcium with exercise activates CAMK 
which upregulates PGC-1α (15). CAMK is also a potent activator of myocyte-enhancer 
factor-2 (MEF2) (91). MEF2 is capable of binding to the nuclear promoter regions of the 
PGC-1α gene, enhancing its transcription (85). As AMP levels increase due to the 
demand of physical activity it interacts with AMPK, which also directly activates PGC-
1α (125). ROS increases during exercise activate p38 mitogen-activated protein kinase 
(p38MAPK) that upregulates PGC-1α (3). ROS signaling also includes the activation of 
AMPK indirectly, although it is possible this is due to the decrease in ATP associated 
with stressful events (53). While ROS signaling leads to biogenesis of mitochondrial 
proteins, excessive ROS is detrimental to the cell. Furthermore, silent mating type 
information regulator 2 homolog (SIRT1) upregulation due to increased levels of 
nicotinamide adenine dinucleotide (NAD+) caused by exercise will deacetylate PGC-1α 
leading to its activation (131). Epinephrine released in response to exercise increases 
adenylyl cyclase leading to increased cAMP. A cAMP dependent protein kinase (PKA) 





element binding protein (CREB) that plays a role in PGC-1α upregulation. Growth 
factors (GFs) such as IGF-1 and insulin, as well as mechanical loading of muscle, 
activate mammalian target of rapamycin (mTOR), a major protein synthesis pathway that 
also promotes PGC-1α activation (21, 94). 
PGC-1α is able to co-activate nuclear respiratory factors (NRFs), specifically 
NRF-1 and NRF-2, nuclear transcription factors responsible for activating many 
mitochondrial proteins (143). When this occurs, TFAM mRNA is transcribed from the 
nuclear genome by NRFs where it is able to be exported to the cytosol for translation, 
imported into the mitochondria, and maintain mtDNA and activate transcription of 
mitochondrial proteins (refer to Figure 4). 
An exercise stimulus is a powerful metabolic signal, as shown above, that 
activates a multitude of signaling pathways in skeletal muscle leading to the transcription 
of TFAM, a key modulator of mitochondrial biogenesis. For these reasons, exercise and 
TFAM are attractive variables to study in skeletal muscle pathology. The above signaling 
pathways connecting these variables are summarized in Figure 5. 
 
Skeletal Muscle Protection  
 Exercise induces a hormetic response in animals. That is, an appropriate dose of 
exercise over time leads to beneficial cellular adaptations to withstand the stress of 
exercise. This process of adaptation is at the essence of evolutionary biology. At extreme 
or high dosages, exercise can be toxic. When appropriate dosages of exercise are applied 





Figure 4. Exercise leading to TFAM. Schematic representing multiple signaling 
pathways created by exercise converging on PGC-1α, which co-activates with NRF-1 and 
NRF-1. This coactivation results in the recruitment of transcriptional machinery to 
nuclear DNA, and ultimately transcribed TFAM mRNA. Through processes described 


























conditions. Exercise has been suggested to increase mitochondrial volume by up to 40% 
(87). This is due to factors of mitochondrial biogenesis being increased with exercise, 
signaling the increase in mitochondrial proteins to be synthesized (refer to Figure 2).  In 
aging skeletal muscle, a rapid decline in muscle mass and muscle performance 
parameters are observed as are decreases in mitochondrial volume and biogenesis. 
Moderate exercise reverses or attenuates the decline in mitochondrial biogenesis markers 
and reduce the age-associated reduction in skeletal muscle mass (75). Although aging is 
its own respective form of skeletal muscle atrophy, this elucidates the idea that exercise is 
able to reverse the effects of atrophy through the induction of mitochondrial biogenesis.  
The type of exercise, volume, intensity, and frequency as well as genetic 
capabilities of the organism will ultimately determine the extent to which muscle cells 
will adapt. Athletes that undergo intense physical exercise, especially endurance training, 
drastically increase the amount of mitochondrial proteins, antioxidant defense, and 
oxidative capabilities as an adaptation that more efficiently produces ATP to meet the 
demands of training. Those participating in lower levels of exercise and physical training 
will also increase mitochondrial proteins and efficiency (75), but generally to a lesser 
degree as stress is reduced and does not require higher levels of adaptation to meet the 
energy demand of the cell. With increased mitochondrial capabilities from exercise 
training, muscle cells will have a greater capacity to produce ATP and greater antioxidant 
scavenging enzymes (133).  This adaptation allows the muscle cells to withstand larger 
levels of stress that would be incurred through physical training by a specific mechanism 





pathways that cause skeletal muscle cellular proteins to be degraded, resulting in a net 
loss of protein over time and in the appearance of the negative effects of atrophy. 
If the previously discussed processes that contribute to protein degradation, cell 
apoptosis, and variation in protein synthesis signaling in skeletal muscle atrophy are 
diminished during an atrophic setting, a reduction in atrophy is observed. Electronic 
stimulation of muscle tissue causing contraction throughout a 14 day hindlimb 
suspension protocol resulted in significant increases in soleus muscle mass compared to 
controls and to an increase in Bcl-2, preventing mitochondrial release of CytC and 
apoptosis (46). As we know, contractile activity, as occurs in exercise, also stimulates 
mitochondrial biogenesis and protein synthesis potentially leading to these results. The 
administration of branched chained amino acids (BCAAs) throughout a 14-day hindlimb 
suspension model of male Wistar rats diminished atrogin-1 and murf-1 protein expression 
and prevented a decrease in soleus mass (56). BCAAs are known to activate mTOR 
pathway signaling and protein synthesis while reducing degradation, resulting in the 
protection of muscle mass, while mTOR activation is implicated in mitochondrial 
biogenesis (Figure 2). In aging mice overexpressing catalase, a ROS reducing enzyme in 
the mitochondria, an improvement in muscle performance and lowered protein oxidation 
was observed compared to aged control mice indicating a crucial role for mitochondrial 
function protecting skeletal muscle (146).  
The results above clearly indicate that different methods associated with 
improving mitochondrial function are capable of improving or preventing skeletal muscle 
loss during atrophy. A question that remains is whether or not the skeletal muscle can be 





abundance of evidence suggesting a correlation between mitochondrial dysfunction and 
atrophy indicate it may be beneficial to target mitochondrial biogenesis to mitigate excess 
ROS and alleviate the dysfunction of mitochondria and the efficiency of ATP production 
as a mechanism to diminish the processes of atrophy. If the muscle cells’ adaptations can 
be sustained for any significant time during a period of unloading, atrophy may be at least 
diminished.  
Fujino et al. analyzed soleus muscle mass in rats after 1 session of endurance 
exercise prior to HLS. This group exercising for one session prior to suspension trended 
higher than the suspension group without exercise in soleus muscle mass, although no 
significant differences were determined (37). These authors also noted a reduction in 
MHC I, a slow myosin heavy chain, protein expression after 14 days of HLS while the 
exercise prior to HLS group trended higher but not significantly. However, one exercise 
session may not be sufficient stress to induce adequate adaptive changes to provide 
significant protection of the muscle over an HLS protocol. A typical beginner exercising 
animal generally will not exercise completely during its first session, as it has not become 
familiarized to the procedure. Multiple training sessions over time allow the animal to 
understand the demands of the procedure while also allowing an exercise protocol to be 
applied that emphasizes a progression over time, leading to a compounding and an 
increased level of adaptation. These heightened adaptations could be key in protecting the 
muscle from atrophy during unloading and disuse. 
Another group used swimming exercise, 3 sessions a week for 4 months, on 
female Wistar rats before immobilizing a hindlimb for 14 days to assess the effect of 





soleus muscle mass compared to rats that did not exercise. A feature of the present study 
was the use of swimming exercise, common in rehabilitation programs, as it does not 
load particular areas of the body that were injured previously while still allowing the 
muscle to contract. This also disallows increased mechanical loading that would be 
experienced in land based exercise, potentially providing different results. Furthermore, 4 
months of exercise training may be difficult to retain adherence in humans. The question 
regarding shorter training protocols used to prevent muscle loss remains. Although this 
study used an immobilization protocol to induce atrophy, it does indicate a possible role 
of exercise in preventing atrophy during acute disuse.   
  
TFAM and skeletal muscle protection. Mitochondrial biogenesis and function require 
TFAM to protect mtDNA from ROS and degradation while activating mtDNA 
transcription of specific proteins. TFAM proteins precede activity of mitochondrial 
biogenesis. Electrical stimulation of rat muscle at 10 Hz for 3 hours/day resulted in an 
initial 55% increase in TFAM by day 4 of stimulation. This was followed by a significant 
import of TFAM into intermyofibrillar mitochondria by day 5 and 7 and increased import 
protein machinery content. Further, by day 7 TFAM binding to the mitochondrial 
promoter increased 49%, the mitochondrial transcript cytochrome c oxidase (COX) III 
subunit protein content increased 65%, and COX enzyme activity increased by 72% (44). 
This study reveals a time schedule of TFAM preceding mitochondrial biogenesis 
processes and the intricate role TFAM plays in mitochondrial biogenesis that occurs 
during skeletal muscle contractile activity. Contractile activity occurs in exercise, and 





Exercise creates an internal environment producing many signals inducing 
mitochondrial biogenesis. The activation of PGC-1α is of particular importance, as it is a 
convergence point of many of the signaling cascades activated by exercise. Kang et al. 
overexpressed PGC-1α in the tibialis anterior muscle of mice through in vivo transfection 
before immobilizing a randomly selected hindlimb for 14 days followed by 5 days of 
remobilization creating an acute period of unloading and disuse of the musculature. After 
7 and 14 days of immobilization, control mice revealed a steady decline in PGC-1α and 
TFAM mRNA expression levels. PGC-1α overexpression resulted in a decrease in ROS, 
increase in mitochondrial functional markers, and reduction in inflammatory markers 
after immobilization and remobilization of the muscle. There was also an increase in 
mtDNA and mitochondrial density. This resulted in the preservation of soleus muscle 
mass after remobilizing previously immobilized muscle (69). 
Cannavino et al. noted reductions in PGC-1α and mitochondrial complexes after 7 
days of hindlimb unloading in mice. This reduction was associated with soleus skeletal 
muscle atrophy. The group further overexpressed PGC-1α in a transgenic mouse model 
and subjected these mice to a similar 7 days of hindlimb unloading. The overexpression 
of this gene prevented catabolic systems, reduced ROS, retained oxidative metabolism, 
and protected soleus muscle mass from atrophy caused by hindlimb unloading (14).   
With the increase in TFAM being a downstream product of upregulating PGC-1α, 
the results of increased mtDNA copy number, mitochondrial density, and mitochondrial 
function are expected. Here we see creating a condition, i.e. overexpressing PGC-1α, 
correlating with TFAM and mitochondrial biogenesis prior to an atrophic protocol in 





direct response to increased PGC-1α, the question of the importance of TFAM 
overexpression alone in skeletal muscle protection remains. The use of TFAM transgenic 
mouse models in the analysis of disuse-induced skeletal muscle atrophy has, to the best 
of our knowledge, not been previously shown. However, while the research using TFAM 
manipulations are scarce, there is data available to begin to analyze the effects of TFAM 
changes in different areas.  
A germ line disruption of the mouse TFAM (TFAM -/-) gene leads to extreme 
decreases in mtDNA and embryonic lethality (111). Nishiyama and colleagues mated 
transgenic mice overexpressing TFAM with mice of a mitochondrial disease model 
containing mutant mtDNA. This resulted in the amelioration of mitochondrial disease and 
prolonged lifespan by increasing mtDNA copy number due to the effects of 
overexpressing TFAM (101). A 2004 study using a combination of TFAM 
overexpression and knockout mice reveals mtDNA copy numbers are directly 
proportional to TFAM levels (31). These studies establish highly specific correlations 
between TFAM, mtDNA, and potential pathology.  
A mouse model with skeletal-muscle specific disruption of TFAM leads to 
mitochondrial myopathy, ragged-red fibers, reduced muscle force, abnormal 
mitochondrial shape, and decreased respiratory chain activity (157). Iyer et al. report an 
in vivo treatment with recombinant TFAM results in increased motor endurance and 
complex-I respiration in mice (54), with both studies linking TFAM directly to skeletal 
muscle health decrements and reduced mitochondrial function. However, treating specific 





Fujino et al. overexpressed a recombinant form of human TFAM (rhTFAM) in 
cultured cardiac myocytes. This rhTFAM rapidly entered the mitochondria and increased 
mtDNA copy number. Electron transport chain proteins (COX I and COX III) were 
elevated, as they are mtDNA encoded while nuclear DNA encoded proteins were not 
significantly elevated. Overexpression of rhTFAM also attenuated pathological 
hypertrophy by blocking the activation of nuclear factor of activated T-cells protein, 
known to induce pathological hypertrophy in cardiac myocytes (38). Again, the data 
shows a correlation between mtDNA copy number and attenuating pathology with this 
example being in cardiac muscle cells, implicating the possibility of TFAM 
overexpression in the treatment of mitochondrial related pathologies in skeletal muscle 
cells. 
Similarly, Ikeda et al. used transgenic mice overexpressing TFAM in a volume-
overload induced heart failure model to observe the effects of upregulated TFAM on 
cardiac muscle after myocardial infarction. TFAM mice exhibited improved cardiac 
function, diminished pathological hypertrophy, and a reduction in cardiac muscle ROS 
compared to control, heart failure mice. Mitochondrial enzymatic activity did not decline 
in the TFAM model, as is seen with the control heart failure mice. This group also used 
rat isolated cardiomyocytes to show an increase in mitochondrial ROS resulted in an 
increase in harmful, degrading proteinases (metallomatrix proteinases, specifically MMP-
2 and MMP-9). Myocytes overexpressing human TFAM resulted in increased mtDNA 
copy number and a suppression of mitochondrial ROS and proteinase activity (51). The 





while also limiting oxidative stress. This also implicates a potential use in skeletal muscle 
to treat ROS-induced pathological conditions, such as atrophy. 
Ikeuchi’s group induced heart failure via myocardial infarction after ligation of 
the left coronary artery in wild-type and TFAM transgenic mice. TFAM mice had an 
attenuation of left-ventricular remodeling and failure as well as no reduction in 
mitochondrial complex activity compared to wild-type mice. Furthermore, TFAM mice 
had a higher survival rate compared to wild-type even with similar infarct sizes. Results 
here provide further evidence in the potential use of TFAM to treat pathological 
conditions in muscle tissue. 
 
Summary. The literature discussed above shows that exercise induces mitochondrial 
biogenesis and function, efficient mitophagy, and increases the cell’s ability to create 
ATP and neutralize ROS. These adaptations have been shown to reduce cell apoptosis, 
increase growth and protein synthesis signaling, and decrease protein degradation 
pathways. Beneficial changes such as these are all in opposition to the disuse-induced 
skeletal muscle atrophic state. Therefore, multiple questions are raised given these 
premises: Will exercise training as a treatment prior to a disuse-induced atrophic scenario 
provide a protective benefit to skeletal muscle?; and if so, is the protective mechanism 
associated with changes in markers of mitochondrial biogenesis and function? 
Furthermore, the above literature also reveals protective effects of PGC-1α during disuse-
induced atrophy and shows beneficial effects of TFAM overexpression in 
cardiomyocytes during pathological scenarios that creates further research questions: If a 





overexpressing TFAM provide a similar protective benefit to skeletal muscle during an 
atrophic scenario?; If overexpressing TFAM is beneficial in cardiomyocytes, will the 
same benefit occur in skeletal muscle during disuse-atrophy? Finally, if both TFAM 
overexpression and exercise protect skeletal muscle, will combining both treatments have 
a synergistic effect? These research questions derived from evidence in the literature led 
to the development of multiple studies to attempt to address if exercise and TFAM 
prevent skeletal muscle atrophy. Refer to Figure 5 for a summary schematic of the 
proposed research. 
Much of this chapter is published as a review article and is referenced as follows: 
Theilen NT, Kunkel GH, and Tyagi SC. The Role of Exercise and TFAM in Preventing 















FIGURE 5. Summary figure. A graphical representation of what this project intends 
analyze: 1. This project intends to observe if exercise prior to a disuse-induce atrophic 
event will prevent atrophy.; 2. With exercise knowingly increasing PGC-1α and TFAM, 
will these mechanisms be associated with redox balance that, when imbalanced, has been 
previously shown to induce degradation and apoptosis as a mechanism of exercise-
preconditioning preventing atrophy?; and 3. We intend to highlight the TFAM pathway 
through TFAM overexpression to see if this molecule is associated with redox balance 























EXERCISE PRECONDITIONING DIMINISHES SKELETAL MUSCLE ATROPHY 
 
Introduction 
Skeletal muscle atrophy results in the reduction of skeletal muscle mass and is 
associated with a decrease in health and quality of life. As muscle mass declines, the 
ability to perform physical tasks is greatly reduced leading to decreased independence 
and increased factors of morbidity and mortality (113). The study of associated molecular 
pathways is of great importance to understand this condition and guide research in the 
development of future therapies.  
One cause of skeletal muscle atrophy occurs during prolonged mechanical 
unloading and disuse of muscle. This can be due to scenarios such as microgravity, 
sedentary lifestyle, bedrest, limb immobilization, and spinal cord injury. Ultimately, each 
of these scenarios encompass a lack of mechanical stress and muscle fiber contraction. 
Profound losses of skeletal muscle may occur under these conditions. As an example, 
many orthopedic injuries and non-orthopedic diseases require bedrest or body 
immobilization around the site of injury. An atrophy rate of approximately 0.5% of total 





conditions (161). Therefore, the need to develop therapies to maintain skeletal muscle 
tissue when entering these settings is worth investigation.  
Atrophy caused by unloading and disuse is characterized by reductions in size, 
weight, and function of the tissue (140). When this occurs, molecular changes leading to 
the net loss of functional protein in muscle tissue are observed. Moreover, previous data 
indicates correlations between muscle atrophy, mitochondrial dysfunction, and increased 
oxidative stress (102, 127). It is well established that excessive reactive oxygen species 
(ROS) observed during muscle atrophy activates protein degradation and cell apoptotic 
pathways while decreasing protein synthesis resulting in a net protein loss (22, 64, 97). 
Similarly, past research reveals ROS also damages functional components of the 
mitochondria leading to reductions in physiologic processes and mitochondrial 
dysfunction. More specifically, excessive ROS mutates unprotected mtDNA leading to 
the translation of defective mitochondrial proteins resulting in mitochondrial dysfunction 
(156). 
Exercise is a powerful stimulator of mitochondrial function (128). On the 
molecular level, exercise activates the master regulator protein of mitochondrial 
biogenesis, peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-
1α), via signaling cascades of acute and immediate changes in circulating and cellular 
molecules a part of the exercise response such as epinephrine, growth factors, AMP, and 
Ca2+ (118). This master regulator co-activates with nuclear-respiratory factors 1 and 2, 
increasing the transcription of mitochondrial transcription factor A (TFAM), a well-






While many studies exist analyzing intra- and post-atrophic setting interventions 
to alleviate atrophy, the development of therapies to prevent these negative changes prior 
to a setting of unloading and disuse is scarce. When entering a known atrophy-causing 
scenario, such as prescribed bedrest or immobilization after elective surgery, being able 
to intervene physical or molecularly directed treatments to prevent muscular atrophy 
could be extremely beneficial for patient quality of life and in reducing financial burdens 
by mitigating medication and rehabilitation costs.  
In a previous review of skeletal muscle atrophy, we proposed a protective effect 
of exercise prior to an atrophic setting and potential molecular mechanisms associated 
(140). Therefore, in the current study we hypothesize exercise training prior to skeletal 
muscle unloading and disuse will increase mitochondrial markers and protect skeletal 
muscle from atrophy. To test this, we use a 7-day hindlimb suspension (HLS) protocol to 
induce muscle atrophy in the hindlimbs of mice compared to mice performing an 18-day 
exercise protocol prior to 7 days of HLS. Results indicate exercise increases 
mitochondrial markers prior to entering HLS and this preconditioning is associated with 
the prevention of skeletal muscle atrophy post-HLS. Exercise is an attractive therapy to 
intervene prior to disuse settings. 
Methods 
Animals and ethical approval. The present study used male C57BL/6J mice (WT). Four 
groups of wild-type mice (WT) were used including a control, hindlimb suspension 
(HLS), exercise prior to hindlimb suspension (Ex+HLS), and exercise only (Ex). Mice 
were sacrificed immediately after HLS treatments and within 48 hours of exercise only 





day of their last exercise session. All mice were 13±1 weeks of age at the time of 
sacrifice. The mice were purchased from Jackson Laboratory (Bar Harbor, ME) and all 
standard procedures and experiments involving animals conformed with the National 
Institutes of Health guidelines and were approved by the Institutional Animal Care and 
Use Committee of the University of Louisville. 
 
Hindlimb suspension. Mice were suspended by the tail in custom built cages to unload 
the hindlimb musculature and induce atrophy for a period of 7 continuous days. Cages 
were constructed as previously shown (36). Briefly, mice were first placed under 
continuous isoflurane anesthesia while a harness was fashioned to the tail. The tail was 
cleaned and surrounded with tape cross-sectionally. A 27-gauge needle cap was cut 
down, as to be open on each end, to ~2 centimeters in length. A small hole was drilled 
into the sidewall of the needle cap and a piece of nylon string was tied into a loop through 
this hole. This cap was then placed on the tail and taped into place roughly 1/3 of the tail 
length from the base. The nylon loop could then be attached to the roof of the cage, 
suspending the animal’s hindlimbs while allowing the forelimbs to bear weight and the 
animal to move around the cage. Mice could also access food and water ad libitum in this 
manner. Bodyweights were recorded before and after suspension. 
 
Exercise protocol. Exercise consisted of 14 training sessions over 18 days of treadmill 
running in a concurrent style. Mice were acclimated to the treadmill during the first four 





sessions and 4 high-intensity interval style exercise sessions. All exercise program details 
(Table 1) were matched between exercising groups. 
 
Laser Doppler. Gastrocnemius arterial blood flow imaging was done for each group 
using a laser Doppler imaging system (Moor FLPI, Wilmington, DE) to assess flux of the 
hindlimb after treatments. Mice were first administered tribromoethanol based on 
bodyweight. The musculature of the left, lower hindlimb was then exposed, revealing the 
musculature of the leg. Each mouse was placed in a prone position and the laser was 
positioned 15 cm from the area of interest. The laser was site directed to a prominent 
vessel on the posterior hindlimb, superficial to the gastrocnemius. Recordings of flux 
were measured for 2 minutes and quantified. 
 
Tissue extraction and weight. Soleus and gastrocnemius tissues were excised and separated 
from each leg in all experimental groups, washed with 50 mmol/L phosphate buffer saline 
(PBS) pH of 7.4, weighed individually, snap frozen in liquid nitrogen, and stored at −80°C 










Table 1. Exercise protocol. Mouse concurrent treadmill exercise protocol consisting of a 
“Week 1” acclimation, followed by progressive training “Week 2” and “Week 3”. Three 
days per week (M,W,F) consisted of endurance-style exercise while two days per week 


































WEEK 1 Monday Tuesday Wednesday Thursday Friday
Warmup 7m/min. for 50m 7m/min. for 50m 7m/min. for 50m 7m/min. for 50m 
Work Rate OFF 7m/min.  8m/min. 9m/min 10m/min.
Rest 3min. off/100m 3min. off/100m 3min. off/100m 3min. off/100m
Distance 300m 300m 300m 300m
WEEK 2 Monday Tuesday-Sprints Wednesday Thursday-Sprints Friday
Warmup 7m/min. for 50m 7m/min. for 50m 7m/min. for 50m 7m/min. for 50m 7m/min. for 50m
Work Rate 11m/min. 15m/min. for 10m 12m/min. 17m/min for 15m 13m/min.
Walk Rate - 7m/min. for 10m - 7m/min. for 15m -
# of Sprints - 8 - 10 -
Rest 3min. off/100m 5mins after 5 sprints 3min. off/100m 5mins after 5 sprints 3min. off/100m
Distance 350m 160m 375m 300m 400m
WEEK 3 Monday Tuesday-Sprints Wednesday Thursday-Sprints Friday
Warmup 7m/min. for 50m 7m/min. for 50m 7m/min. for 50m 7m/min. for 50m 7m/min. for 50m 
Work Rate 13.5m/min. 18m/min. for 15m  14m/min. 20m/min. for 20m 14.5m/min.
Walk Rate - 7m/min. for 15m - 5x-7m/20m; 6x-7m/10m -
# of Sprints - 11 - 11 -
Rest 3min. off/100m 5mins after 5 sprints 3min. off/100m 5mins after 5 sprints 3min. off/100m





Immunofluorescence. A portion of each muscle was cut cross-sectionally at the midbelly 
and immersed in tissue-freezing medium (Triangle Biomedical Sciences, Durham, NC, 
USA) in disposable plastic tissue-embedding mold (Polysciences Inc., Warrington, PA, 
USA). The tissue blocks were immediately frozen and kept at -80°C until use. 7-10 µm 
thick sections were obtained from each muscle using a Cryocut System (CM 1850; Leica 
Microsystems, Buffalo Grove, IL, USA). Tissue sections were placed on Poly-L-Lysine 
coated microscope slides (Polysciences, Inc., Warrington, PA, USA). Tissue sections were 
fixated in acetone for 20 mins, washed in 1X PBS-T solution, and were incubated with 
permeabilization solution (0.2 g Bovine Serum Albumin, 3 ul Triton X-100 in 10ml 1X 
PBS) for 1 hour at RT followed by another washing step with 1X PBS-T. The sections 
were incubated with primary antibody (anti-Laminin; Abcam, Cambridge, MA, USA) 
dilution of 1:200 overnight at 4°C. After washing with 1X PBS-T the slides were incubated 
with a fluorescently labeled secondary antibody (goat anti-mouse Alexa flour 594; 
Invitrogen, Waltham, MA, USA) with a 1:300 dilution for 1 hour at RT. After another 
washing step, slides were mounted with mounting medium and glass cover slips, then 
visualized using a laser scanning confocal microscope (Olympus Fluo View 1000; Center 
Valley, PA, USA). Cross-sectional area measurements were acquired using laminin images 
by hand tracing single, stained muscle fibers in ImageJ software (123).  
 
DHE Staining. After excision, each muscle was cross sectioned in half, immediately placed 
in tissue-freezing medium (Triangle Biomedical Sciences, Durham, NC, USA), snap 
frozen and stored at -80°C until use. Samples were then sectioned on a cryostat, placed on 





oxidative fluorescent dye dihydroethidium (DHE). Cryosections (10 μm) were incubated 
with DHE (2 μmol/l) in PBS. After washing, slides were mounted with mounting medium 
and a cover slip, then visualized using a laser scanning confocal microscope (Olympus 
Fluo View 1000; Center Valley, PA, USA).  
 
Protein Estimation. Muscle tissue samples were bead-homogenized in ice‐cold RIPA (1 
mmol/L) buffer with PMSF and protease inhibitor cocktails (1 μL/mL of lysis buffer, 
Sigma Aldrich, St. Louis, MO). The samples were then centrifuged at 12,000 g for 20 min 
at 4°C. The supernatant was extracted and stored at −80°C until use. Protein estimation 
was measured by the Bradford‐dye (Bio‐Rad, CA) method in a 96‐well microliter plate 
against a Bovine Serum Albumin (BSA) standard. The plate was analyzed at 594 nm in a 
Spectra Max M2 plate reader (Molecular Devices Corporation, Sunnyvale, CA). 
 
Western Blot Analysis. Protein lysates (40 µg) were prepared and heated at 95°C for 5 min 
and loaded in an SDS polyacrylamide gel in running buffer and run at a constant current 
(75 Volts). Proteins were then transferred to a PVDF membrane overnight at 120 mA at 
4°. After transferring, the membranes were blocked in 5% nonfat milk for 1 hour at room 
temperature followed by overnight incubation with primary antibodies (Anti-PGC-1α, 
Anti-TFAM, Anti-SMHC, Anti-CS; Abcam, Cambridge, MA, USA.) at 4°C. After 
washing with TBS-T buffer, membranes were incubated with secondary antibodies (horse 
radish peroxidase- conjugated goat anti-mouse, goat anti- rabbit IgG; Santa Cruz 
Biotechnology, Dallas, TX, USA) for 1 hour at RT with 1:5000 dilution followed by 





(GE Healthcare, Piscataway, NJ, USA) and all images were recorded in the gel 
documentation system ChemiDoc XRS (Bio-Rad, Richmond, CA, USA). The membranes 
were stripped with stripping buffer (Boston BioProducts, Ashland, MA, USA) followed by 
a blocking step with 5% milk for 1 hour at RT. After washing, membranes were incubated 
with anti-Gapdh antibody (Millipore, Billerica, MA, USA) as a loading control protein. 
PGC-1α and SMHC were visualized on the same gel while TFAM and CS were visualized 
on the same gel, due to size similarities. The data were analyzed by Bio-Rad Image Lab 
densitometry software and normalized to anti-Gapdh bands. 
 
Quantitative PCR. To assess mRNA expression of different genes in skeletal muscle, RNA 
was isolated with TRIzol® reagent (Life Technologies, Carlsbad, CA, USA) according to 
manufacturer's instructions. The RNA quantification and purity was assessed by nanodrop-
1000 (Thermo Scientific, Walthan, MA, USA). Aliquots (2μg) of total RNA were reverse-
transcribed into cDNA using a High Capacity cDNA Reverse Transcription Kit (Applied 
Biosystems, Foster City, CA) according to the manufacturer’s protocol. q-PCR was 
performed for different genes (PGC-1α, TFAM, CS, Myh4, Myh7, SOD-1, SOD-2), in a 
final reaction volume of 20 µl containing 10 µl of PerfeCTa SYBR Green SuperMix, Low 
ROX (Quanta Biosciences, Gaithersburg, MD), 6 µl nuclease free water, 2µl cDNA, 40 
picomoles of forward, and reverse primers. All sequence-specific oligonucleotide primers 
(Invitrogen, Carlsbad, CA, USA) are presented in (Table 2). The data reported from q-PCR 
is represented in fold expression, calculated as the cycle threshold difference between 





























Gene Forward Nucleotide Sequence  Reverse Nucleotide Sequence 
Myh7 
5’- ATCAAATCATCCAAGCCAACCC 5’- GAGGAGTTGTCATTCCGAACTG 
Myh4 
5’- TTGTGGTGGATGCTAAGGAGTC 5’- GTACTTGGGAGGGTTCATGGAG 
CS 
5’ - CACTGTTGAGATGGACACACTG 5’ – TCCTGAAGTCTGCATCATGACT 
SOD-1 5’- GAACCAGTTGTGTTGTCAGGAC 5’- GCCTTGTGTATTGTCCCCATAC 
SOD-2 5’- GGTCACAGTTTCACAGTACACC 5’- TCACAGCCTTGAGTTACAGAGT 
TFAM 
    5’ - GAGAGCTACACTGGGAAACCACA    5’ – CATCAAGGACATCTGAGGAAAA 
PGC-1a 5’- CTTTCTGGGTGGATTGAAGTGG 5’- CTCAAATATGTTCGCAGGCTCA 
Rn18S 
5’- CACGGACAGGATTGACAGATTG 5’- GACAAATCGCTCCACCAACTAA 
ß-actin 

















Statistical Analysis. All data were expressed as means ± SE. One-way ANOVA analyses 
were conducted on each data set with Tukey’s post-hoc analysis used between groups after 
significance was obtained. Significance was determined as a p-value<.05.  
 
Results 
Exercise diminishes loss of CSA and weight. Wet muscle weight was measured 
immediately after excision. Muscle weights were standardized to bodyweight (mg/g) to 
account for individual size variation (Table 3). HLS resulted in a significant decrease 
(p=.001) of 27.1% in soleus muscle and a significant decrease (p=.001) of 21.5% in 
gastrocnemius muscle weight to bodyweight ratio compared to Control. Exercising prior 
to HLS resulted in only a 5.6% non-significant decrease (p=.50) in soleus muscle and an 
8.1% non-significant decrease (p=.16) in gastrocnemius weight to bodyweight ratio 
(Table 3). Both the soleus and gastrocnemius Ex+HLS group ratios were significantly 
greater than the HLS group (p=.001 and p=.007, respectively). Furthermore, cross-
sectional area (µm2) differences followed a similar trend with HLS resulting in a 
significant decrease compared to Control (p<.01), while Ex+HLS and Ex groups were 
both significantly greater than HLS (p<.01) (Fig. 6 and 7). 
 
Hindlimb blood flow is not a limiting factor. Laser Doppler imaging of the left hindlimb 
assessed blood flow through a prominent posterior limb artery superior to the 
gastrocnemius (Fig. 8). This measurement is a function of red blood cell (RBC) content 
and the velocity of RBCs through the vessel of interest. Changes in RBC content and 





Table 3. Bodyweight and muscle weights. Bodyweight (BW) pre-HLS (g) and BW at 
time of sacrifice. Muscle weight of both the soleus and gastrocnemius. All data presented 
as means ± SE. Statistical significance (p<.05) between groups indicated by the 































































Figure 6. Soleus CSA. A. Immunofluorescence laminin staining of soleus muscle fibers. 
All pictures are 200 µm in width.  B. Cross-sectional area (µm2) measurement acquired 
using ImageJ software (n=6). Statistical significance (p<.05) indicated by the 









































Figure 7. Gastrocnemius CSA. A. Immunofluorescence laminin staining of 
gastrocnemius muscle fibers. All pictures are 200 µm in width. B. Cross-sectional area 
(µm2) measurement acquired using ImageJ software (n=6). Statistical significance 








































Figure 8. Hindlimb blood flow. A. Laser Doppler blood flow measurement of 
prominent vessel in the dorsal hindlimb. B. Blood flux measurement comparison between 
groups (n=6, p<.05). Statistical significance (p<.05) indicated by the corresponding group 









































nutrient delivery along with waste removal are different between groups. Here we show 
while Ex tended to increase blood flow in this particular vessel, there were no significant 
differences between groups (p=.53). 
 
Exercise increases functional muscle protein. According to Sliding Filament Theory, 
skeletal muscle contraction results from the cyclic interaction of actin and myosin 
molecules and the recycling of ATP (49). Loss of these protein molecules is an indicator 
of muscle atrophy and correlates with decreased fatigue resistance of the muscle (34, 57). 
HLS resulted in a no significant change in slow myosin heavy chain (SMHC) protein 
expression in the soleus muscle and a significant decrease in the gastrocnemius muscle 
(Fig. 9 and 10). However, exercise prior to HLS resulted in a significant increase in 
SMHC in the gastrocnemius compared to the HLS group (p<.05). Furthermore, exercise 
only significantly increased SMHC compared to controls in soleus (p=.014) and 
gastrocnemius (p<.01). Using qPCR, we followed up protein expression of SMHC with 
gene expression analysis of a slow myosin heavy chain gene, Myh7. In the soleus, Myh7 
approached a significant decrease (p=.056) in HLS compared to Control (.94 vs. 1.1, 
respectively). In the gastrocnemius, Myh7 was significantly decreased in both HLS and 
Ex+HLS compared to Control and Ex with no difference being observed in the Ex group 
transcripts compared to control (Fig. 10). 
Moreover, disuse of skeletal muscle and cessation of exercise training is 
associated with fiber-type transitioning from a slow, more oxidative muscle to a fast, 
more glycolytic muscle fiber-type composition (23). We therefore assessed the transcript 





Figure 9. Soleus MHC analysis. A. Soleus slow myosin heavy chain protein expression 
(n=6). B. Western blot analysis of soleus SMHC. Statistical significance (p<.05) between 
groups indicated by the corresponding group letter. C. Myosin heavy chain 7 (slow-
twitch muscle) gene expression analysis by qPCR. D. Myosin heavy chain 4 (fast-twitch 










































Figure 10. Gastrocnemius MHC analysis. A. Gastrocnemius slow myosin heavy chain 
protein expression. B. Western blot analysis of gastrocnemius SMHC. Statistical 
significance (p<.05) between groups indicated by the corresponding group letter. C. 
Myosin heavy chain 7 (slow-twitch muscle) gene expression analysis by qPCR. (groups: 









































of the Myh4 gene. As expected, in soleus tissue HLS resulted in a significant increase in 
Myh4 mRNA compared to Control (21.34 vs 1.15, p<.01). Although Ex+HLS Myh4 
transcript levels were significantly elevated from Control, results indicated less mRNA 
expression of Myh4 compared to HLS (p<.01) (Fig. 9).  
 
Mitochondrial markers increase with exercise. Skeletal muscle atrophy is associated with 
mitochondrial dysfunction (86, 127). Markers of mitochondrial biogenesis and function 
were measured via qPCR and Western Blotting analyses to assess our hypothesis that 
exercise increases these markers which are correlated with the protection of muscle 
weight and size during HLS. To test this correlation, we assessed the transcript and 
protein expression of PGC-1α, TFAM, and CS. 
In assessing mitochondrial biogenesis, we measured PGC-1α transcript expression 
to be significantly increased after the exercise protocol (Ex) in both soleus (Fig. 11) and 
gastrocnemius muscles (Fig. 12) compared to Control (2.3-fold and 1.6-fold, 
respectively). PGC-1α mRNA levels were significantly decreased in the gastrocnemius 
after HLS. The Ex+HLS group, while lower than Ex, was still significantly greater than 
HLS in the gastrocnemius (1.12 vs .87, p=.004). Transcript expression of PGC-1α 
between Control, HLS, and Ex+HLS in the soleus were not significantly different. 
Protein expression of PGC-1α in the soleus muscle (Fig. 11) was significantly greater in 
Ex compared to Control (p<.05) while HLS was significantly reduced (p<.05). Ex+HLS 
expression of PGC-1α was significantly greater than HLS alone (p<.05). In 





Figure 11. Soleus mitochondrial analysis. A. Soleus protein expression via western blot 
of mitochondrial markers (SMHC/PGC-1α and TFAM/CS expression measured on same 
blots with same loading control, due to size similarities). B. Western blot analysis of 
soleus muscle mitochondrial markers. Statistical significance (p<.05) between groups 
indicated by the corresponding group letter. C. Gene expression analysis by qPCR of 






















         
 
                                                 
        








Figure 12. Gastrocnemius mitochondrial analysis. A. Gastrocnemius protein 
expression via western blot of mitochondrial markers (SMHC/PGC-1α and TFAM/CS 
expression measured on same blots with same loading control, due to size similarities). B. 
Western blot analysis of soleus muscle mitochondrial markers. Statistical significance 
(p<.05) between groups indicated by the corresponding group letter. C. Gene expression 























          
 
 








expression (p<.01). Furthermore, in gastrocnemius muscle HLS decreased PGC-1α 
compared to Control (p<.01). TFAM transcript expression significantly increased in the 
soleus (Fig. 6) and increased in trend in the gastrocnemius muscle (Fig. 7) after the 
exercise protocol (Ex) compared to Control (1.74 vs 1.03 [p<.05], 1.47 vs 1.09 [p=.30], 
respectively). Soleus muscle TFAM transcript levels were not significantly different 
between Control, HLS, and Ex+HLS (1.03 vs .83 vs 1.07, respectively) with Ex+HLS 
trending greater than HLS (p=.07). TFAM mRNA expression levels in the gastrocnemius 
significantly decreased after HLS (p=.016), with the Ex+HLS group being significantly 
greater than HLS (3.16 vs .49, p=.001). Protein expression of TFAM was found to be 
elevated in Ex compared to Control in both muscles (p<.05). HLS only resulted in no 
significant decrease in TFAM protein expression in the soleus and a significant decrease 
in the gastrocnemius (p<.05) (Fig. 6 and 7) compared to Control while TFAM of 
Ex+HLS was elevated significantly compared to HLS only in the gastrocnemius (p<.05).  
Citrate synthetase is a tricarboxylic acid cycle enzyme catalyzing citrate from 
acetyl-CoA and oxaloacetate. It is a commonly used biomarker to assess mitochondrial 
function and density in skeletal muscle (151). Analysis of the mRNA expression in the 
soleus (Fig. 6) revealed greater CS expression in the HLS group compared to Ex+HLS 
(p<.05) with no differences between Control, HLS, and Ex groups. Soleus CS protein 
expression (Fig. 7) decreased in the HLS group compared to Controls (p<.05) while 
Ex+HLS trended greater than HLS but did not reach significance. Moreover, exercise 
increased CS protein in soleus muscle compared to all other groups (p<.05). In the 
gastrocnemius muscle (Fig. 7), CS mRNA transcripts were significantly reduced in HLS 





significantly different compared to control but were both significantly greater than HLS 
(p<.05). Furthermore, Ex was significantly greater than HLS (p<.05). Protein expression 
of CS (Fig. 7) increased significantly in the Ex group compared to all other groups. 
However, there were no significant differences between Control, HLS, and Ex+HLS.  
 
Exercise prior to HLS may reduce ROS. Reactive oxygen species are implicated in the 
induction of protein degradation and apoptotic pathways, potentially being an important 
contributor to the atrophic muscular condition (22). In order to visualize ROS 
accumulation, we used a dihydroethidium staining (DHE), solely as an observational 
assessment. DHE staining is commonly used to visualize ROS and in previous research is 
viewed as the least problematic and most specific ROS dye, due to its ability to easily 
permeate cell membranes and its specificity for superoxide anion (106). Observationally, 
there were clear differences between groups (Fig. 13 and 14). HLS, as expected, resulted 
in greater levels of ROS in both muscles. Ex+HLS appears to be reduced compared to the 
excessive positive staining for superoxide anion in the HLS group. 
Superoxide dismutases are the main antioxidant defense system against 
superoxide anions (39). Therefore, we measured SOD-1 and SOD-2 (mitochondrial SOD) 
transcripts via qPCR and SOD-2 protein expression via Western blot to assess any 






Figure 13. Soleus ROS and antioxidants. A. Observational soleus dihydroethidium 
staining for ROS. Bright spots are assumed to be positive staining for superoxide anion 
(n=6). B. Soleus protein expression via Western blot analysis for antioxidant enzyme 
SOD-2. Statistical significance (p<.05) between groups indicated by the corresponding 
group letter. C. Soleus SOD-1 and SOD-2 gene expression via qPCR. (groups: n=6, 


















        
    














Figure 14. Gastrocnemius ROS and antioxidants. A. Observational gastrocnemius 
dihydroethidium staining for ROS. Bright spots are assumed to be positive staining for 
superoxide anion (n=6). B. Gastrocnemius protein expression via Western blot analysis 
for antioxidant enzyme SOD-2. Statistical significance (p<.05) between groups indicated 
by the corresponding group letter. C. SOD-1 and SOD-2 gene expression via qPCR. 


















           
      














significant increase in SOD-2 protein expression after exercise (Ex) (P>.01) compared to 
all other groups with a trending decrease in SOD-2 expression in HLS. Gastrocnemius  
SOD-1 and SOD-2 mRNA expression of the Ex+HLS group was significantly greater 
than all other groups (p<.01). SOD-2 protein expression in this muscle was significantly 
greater in both Ex and Ex+HLS groups compared to both Control (p<.01) and HLS 
(p<.01), respectively.  
 
Discussion 
Skeletal muscle atrophy is the result of an imbalance of protein degradation and 
protein synthesis. When degradation exceeds synthesis, the result is a loss of muscle 
mass. The correlation between skeletal muscle atrophy and reduced mitochondrial 
biogenesis and function (114, 116) as well as increased or unbalanced reactive oxygen 
species accumulation is well demonstrated in the literature (33, 102). Furthermore, a 
wealth of research reveals exercise training increases markers of mitochondrial function 
and biogenesis (44, 75, 87). Therefore, the aim of this study is to assess the effects of 
preconditioning the muscle tissue with a short-term exercise protocol prior to hindlimb 
unloading as a treatment to prevent atrophy. Secondarily, we aim to analyze 
mitochondrial molecular mechanisms associated with exercise preconditioning as a 
protective therapy.    
Initially, Doppler laser technology used on the hindlimbs of all mice groups under 
anesthesia assessed blood flow. Differences in oxygen and nutrient delivery as well as 





differences in tissue health. Prior research in this area reveals a disconnect in blood flow 
assessment and atrophy. Nevertheless, according to a 2001 review of microvasculature 
changes with disuse atrophy by Tyml et al., multiple animal studies reveal no changes in 
blood flow in atrophied muscle as well as no differences in mean blood pressure and 
vascular resistance (145). Similarly, our measurements reveal no significant differences 
between all groups, indicating these tissues changes are not RBC and velocity related. 
Here, we did not account for capillarization and global microvasculature of each muscle, 
given our laser was solely directed at a more prominent vessel of the gastrocnemius due 
to the constraints of this particular technology. This assessment may account for group 
differences and is a limitation of the current study warranting future consideration.   
In the disuse model of HLS in mice, previous research shows signs of muscle 
atrophy that include changes in muscle weight, CSA, and fiber-type transitioning. 
Atrophy may occur in as little as 3 days (14), while other studies reveal atrophy occurring 
after 7 or more days of disuse (56, 66, 116). In the present study, we similarly observe 
muscle atrophy occurring after 7 days of HLS in both the soleus and gastrocnemius 
muscles, indicated initially by reductions in the weight and size of the muscle. 
Numerous studies have also intervened various treatments to reduce the effects of 
atrophy on skeletal muscles including electrical stimulation, nutrition, and exercise intra- 
or post-HLS (1, 46, 56, 104, 136). However, studies specifically measuring the effects of 
interventions, specifically exercise training, pre-HLS are scarce. Here we report greater 
muscle weight and cross-sectional area along with decreased slow-to-fast fiber-type 
transitioning in mice exercising prior to HLS compared to mice undergoing only HLS. 





were treated with 4 months of swimming exercise before having their hindlimbs 
immobilized for 5 days in orthosis to induce atrophy (112). Although many differences 
exist between these studies, the researchers report exercise training prior to 
immobilization preserves soleus muscle mass compared to rats without exercise training. 
Fujino et al. measured soleus muscle mass after treating rats with 1 session of 
endurance exercise prior to HLS and, while the exercise group trended higher than the 
suspension group, no significant differences were determined (37). This group also noted 
reductions in MHC I, a slow MHC, after 14 days of HLS while the group exercising 
before HLS trended higher but not significantly. However, a single exercise session may 
not be enough stress to induce adequate adaptive changes to provide significant 
protection of the muscle over an HLS protocol. Furthermore, adapting to exercise 
requires time and can be repetitiously surmounted to achieve, incrementally, greater 
adaptations. Such is the foundation of progressive exercise training (142). The use of a 
single session negates the factor of time to allow incremental increases in adaptation and 
potentially greater skeletal muscle protection. However, shorter-term exercise programs 
may be more translatable and useful in human adherence. Therefore, we used a 
concurrent protocol in this study that combines aerobic and anaerobic adaptive stressors 
over a shorter period (18 days) while still allowing enough time for adaptations to 
surmount. Our results indicate similar SMHC results as the Fujino et al. study in the 
soleus muscle between these groups and we also report a significant increase in 
gastrocnemius SMHC in the group exercising before HLS, potentially revealing muscle 





It is well-established a reduction in markers of mitochondrial biogenesis and 
function are correlated with skeletal muscle atrophy (67, 99, 116). Liu et al. observed 
diminished mitochondrial respiration prior to activation of protein degradation pathways 
in a toxin-induced mouse atrophy model (86) while another group observed markers of 
mitochondrial biogenesis increasing prior to the regeneration of muscle after atrophy 
(28), indicating potential timelines of effect of mitochondrial function. The present 
research similarly revealed significant decreases in PGC-1α in both muscles while 
tending to decrease TFAM in the soleus and significantly decreasing TFAM in the 
gastrocnemius after HLS. We also observed decreases in trend and with significance of 
CS, a commonly used marker of mitochondrial function, across both muscles (81) 
establishing evidence for mitochondrial changes being correlated to the atrophy in the 
present study. 
Based on this evidence, exercise was chosen as a preconditioning treatment to 
prevent disuse-associated atrophy because of the well-known inducing effect it has on 
mitochondrial biogenesis, particularly PGC-1 α and TFAM, and mitochondrial function 
(61, 87, 119). Indeed, our measurements of the Ex group mirrored this previous research, 
as we observed increases in gene expression and protein content across both muscles in 
many of these markers after the exercise protocol. It may be the increased molecular 
mitochondrial adaptations achieved by exercise provides enough lasting, anti-atrophic 
benefits over a 7-day HLS protocol to diminish the negative effects on skeletal muscle. 
Moreover, muscle protein synthesis is a high-ATP consuming process and studies suggest 
a mitochondrial dysfunction role being at the center of diminished muscle protein 





is also well known to activate protein synthesis pathways (Akt/mTOR) in skeletal muscle 
(24). Therefore, by concentrating on treating the mitochondria through exercise we 
attempt to shift the balance of degradation and synthesis towards saving muscle tissue. 
We also find a wealth of evidence in prior research establishing protein 
degradation markers upregulated with muscle disuse (30, 56) and ROS as a prominent 
inducer of protein degradation pathways (ubiquitin-proteosome pathway, NF-κB, murf-1, 
atrogin-1/MAF-bx), apoptotic pathways, and mitochondrial dysfunction in skeletal 
muscle atrophy (22, 64, 97). Experiments quantifying ROS are generally variable, 
leading our account for ROS through DHE staining to be strictly observational in 
searching for particular trends between groups. Indeed, we observe high expression of 
ROS, specifically superoxide anion, in both muscles after HLS while exercising prior to 
HLS resulted in lower expression of ROS indicating a potential connection between ROS 
and muscle health in the present study. Cannavino et al. reported similar results through 
DHE staining, showing significant increases in superoxide anion after a 7-day hindlimb 
suspension in mice (14).  
The mitochondrial respiratory chain is responsible for ATP production but also 
produces superoxide anion under normal physiologic circumstances, mainly from 
complex I and complex III (26). It is the excessive and unbalanced accumulation of ROS 
that leads to deleterious effects of mitochondrial and cellular proteins associated with 
atrophy. SOD-1 and SOD-2 (mtSOD) are antioxidants that neutralize ROS by accepting 
the unpaired electron of superoxide anion and converting to hydrogen peroxide, which is 
then further converted to water in the presence of glutathione peroxidase. Exercise 





oxidative stress caused by increased respiration and  results in an adaptation of increased 
levels of SOD over time to neutralize superoxide anions (133). Here, we also observe 
increased SOD-2 antioxidant expression in both muscles after the exercise protocol in the 
present study. The gastrocnemius revealed elevated levels of SOD-2 after Ex+HLS in 
both the mRNA and protein expression and not only after the exercise protocol (Ex) like 
that of the soleus. The gastrocnemius may be able to better withstand ROS accumulation 
during atrophic settings after exercise training due to a greater and more lengthy SOD-2 
response. While the soleus muscle revealed increased SOD-2 after exercise, by the time 
the HLS protocol was over levels were not significantly different compared to HLS 
indicating potential differences among muscle fiber types. The change in antioxidants 
may potentially provide a protective effect against ROS that accumulates during disuse 
and further implicates exercise as an effective preconditioning treatment.  
 
Conclusions. Skeletal muscle atrophy is correlated with reduced mitochondrial biogenesis 
and function along with excessive ROS leading to the activation of protein degradation 
and apoptotic pathways as well as reductions in protein synthesis. Here we show exercise 
training prior to an atrophic setting protects skeletal muscle from HLS-induced atrophy 
by inducing the potentially protective molecular effects of increased markers of 
mitochondrial biogenesis and function with increased antioxidant status. Exercise training 
prior to an atrophic setting may be a useful intervention to alleviate skeletal muscle 
atrophy caused by disuse and unloading. Furthermore, mitochondrial directed treatments 















Skeletal muscle functions not only in propulsion for locomotion but also as a 
glucose and amino acid reservoir (117). It is the largest organ in the body and functions 
as an endocrine secretory tissue (109). Notably, skeletal muscle strength is a key 
predictor of life span (92) and vitality. Being that this muscle functions in a variety of 
important processes, pathological losses can greatly affect health and quality of life.  
Skeletal muscle atrophy is the loss of muscle tissue and is characterized by a 
decline in muscle mass leading to reductions in force production, decreased cross-
sectional area of the muscle fibers, and diminished oxidative ability (140). As this tissue 
atrophies, the ability to perform physical tasks is greatly reduced and can significantly 
decrease the physical independence of the patient as well as increase factors of morbidity 
and mortality (113). Furthermore, when patients enter a scenario in which atrophy occurs, 
resources must be devoted to the mitigation and recovery process, such as 
pharmacological interventions or the use of rehab specialists. Therefore, preventing the 
condition of skeletal muscle atrophy is an important research endeavor to improve the 





While many scenarios may cause skeletal muscle atrophy (disease, starvation, and 
aging), the mechanical unloading and disuse of muscle results in specific atrophic 
changes. Skeletal muscle is abnormally disused or unloaded during circumstances such as 
bedrest, limb immobilization, spinal cord injury, microgravity, and a sedentary lifestyle 
(162). During all of these scenarios, significant reductions in fiber contraction and 
mechanical stress on the muscle tissue occur, leading to potentially abrupt and reductive 
structural and molecular changes (55).  
Disuse-induced atrophy results in the loss of muscle fiber size, weight, and 
function (16). When this occurs, decreases in molecular signaling pathways leading to 
protein synthesis and increases in molecular pathways leading to protein degradation and 
apoptosis are observed, resulting in a net loss of muscle protein (55, 141). These 
molecular mechanisms are also correlated with mitochondrial dysfunction and redox 
imbalance (102, 127). Dysfunctional mitochondria and excessive reactive oxygen species 
(ROS) accumulating during muscle atrophy reduces protein synthesis and activates 
protein catabolic mechanisms (22, 64, 97). ROS, in particular, can accumulate in the 
mitochondria and damage mtDNA, leading directly to dysfunction through the mutation 
of mtDNA and the transcription and translation of dysfunctional mitochondrial proteins 
(156).  
Exercise powerfully stimulates mitochondrial function through small molecular 
changes that occur with physical activity and converge on the upregulation of the master-
regulator protein, peroxisome proliferator-activated receptor gamma coactivator 1-alpha 
(PGC-1α) (118). This master regulator co-activates with nuclear-respiratory factors 1 and 





Translated TFAM is translocated into the inner-mitochondrial matrix and re-folded into 
its mature form where it can interact with mtDNA leading to increased mtDNA 
transcription. TFAM also abundantly binds mtDNA forming histone-like nucleoid 
structures to store, maintain, and protect mtDNA from binding and degradation via ROS 
(79). 
Substantial evidence in prior research implicates the strong link of TFAM and 
mitochondrial health. Reviewing animal studies of TFAM, we see a germ line disruption 
of the mouse TFAM (TFAM -/-) gene leading to extreme reductions in mtDNA and 
embryonic lethality (111). A 2004 study using a combination of TFAM overexpression 
and knockout mice reveals mtDNA copy numbers are directly proportional to TFAM 
levels (31). Balliet et al. showed a lack of TFAM resulted in mitochondrial dysfunction 
due to the loss of OXPHOS proteins (148). In contrast, an in vivo treatment with a 
recombinant form of TFAM resulted in increased motor endurance and complex-I 
respiration in mice (54).  
There is evidence in a limited number of in vivo and in vitro TFAM 
overexpression studies that reveal decreased left-ventricular remodeling after myocardial 
infarction and an overall protective role of TFAM in cardiomyocytes (38, 52), 
establishing the important role of TFAM in a muscle tissue. In skeletal muscle, a mouse 
model with a skeletal-muscle specific disruption of TFAM led to mitochondrial 
myopathy, ragged-red fibers, reduced muscle force, abnormal mitochondrial shape, and 
decreased respiratory chain activity (157) specifically indicating its vital role in skeletal 
muscle. During skeletal muscle differentiation, increases in TFAM mRNA levels 





protein levels are regulated by the availability of TFAM mRNA (18). Furthermore, we 
see overexpressing PGC-1α in a mouse model prevents disuse-induced skeletal muscle 
atrophy of the soleus (14). With TFAM being transcribed downstream of PGC-1α and 
tightly associated with mitochondrial function, a TFAM mechanism of skeletal muscle 
protection may exist. There are no known studies, to the best of our knowledge, 
analyzing TFAM overexpression in a mouse disuse-induced skeletal muscle atrophy 
model.  
Therefore, we hypothesize overexpressing TFAM in mouse skeletal muscle will 
prevent or diminish unloading and disuse-induced atrophy. To test this, we use a 7-day 
hindlimb suspension (HLS) protocol to induce muscle atrophy in the hindlimbs of mice 
to be compared with wild-type mice entering the same HLS protocol. While we have 
separately shown exercise prior to HLS diminishes atrophy in wild-type mice (article in 
submission), here we further aim to observe if exercising TFAM overexpression 
transgenic mice prior to HLS results in a combination treatment effect to prevent muscle 
atrophy. Our results indicate overexpressing TFAM results in significantly diminished 
soleus and gastrocnemius atrophy prompting potential future research in genetic and 
molecularly directed therapies. 
 
Methods 
Animal and ethical approval. Male C57BL/6J mice (WT) and male C57-based transgenic 
mice overexpressing the TFAM gene (Cyagen Bioscience, Inc.) were used for analysis. 





The TFAM transgenic groups consisted of a control (T-Control), hindlimb suspension (T-
HLS), and exercise prior to hindlimb suspension (T-Ex+HLS). Four groups of wild-type 
mice (WT) were used as comparison to transgenic groups including a Control, hindlimb 
suspension (HLS), exercise before hindlimb suspension (Ex+HLS), and exercise only 
(Ex) group. All data from WT mice are derived from our recent work and are being 
submitted in combination with the present study for publication. WT data will be used 
solely as comparative data for the objectives of this study. Mice that exercised prior to 
suspension were placed in HLS the same day after their last exercise session and all mice 
were sacrificed immediately after HLS. All mice were 13±1 weeks of age at the time of 
sacrifice. Wild-type mice were purchased from Jackson Laboratory (Bar Harbor, ME) 
and transgenic mice were purchased from Cyagen Biosciences, Inc. (Santa Clara, CA). 
All standard procedures and experiments involving animals were approved by the 
Institutional Animal Care and Use Committee of the University of Louisville and 
conformed with the National Institutes of Health guidelines. 
 
Hindlimb suspension. Custom built cages were used to unload the hindlimb musculature 
and induce atrophy for 7 continuous days. Cage construction followed similar guidelines 
as previously shown (36).  Briefly, mice were first placed under continuous isoflurane 
anesthesia while a tail harness was attached. The tail was cleaned then taped cross-
sectionally. A 27-gauge needle cap was cut down to ~2 centimeters in length with 
openings on each end. A small hole was created in the sidewall of the needle cap and a 
nylon string was used to tie a loop through this hole. This cap was placed over the tail 





now taped to the tail, could then be attached to the roof of the cage, suspending the 
animal’s hindlimbs. This also allowed the forelimbs to bear weight and the animal to 
move around the cage. Mice could also access food and water ad libitum in this manner. 
Bodyweights were recorded before and after suspension. 
 
Exercise Protocol. Exercise consisted of 14 training sessions over 18 days of treadmill 
running in a concurrent style of exercise (combining more than one mode of exercise). 
An acclimation period to treadmill exercise occurred during the first four sessions. The 
following 10 sessions consisted of 6 endurance training style exercise sessions and 4 
high-intensity interval style exercise sessions. All exercise program details (Table 4) were 
matched between exercising groups. 
 
Laser Doppler. Laser Doppler imaging (Moor FLPI, Wilmington, DE) of lower, hindlimb 
blood flow was done for each group and used to assess flux of the hindlimb after 
treatments. Mice were first administered anesthesia (tribromoethanol) standardized to 
bodyweight. The musculature of the left, lower hindlimb was then exposed, revealing the 
musculature of the leg. Each mouse was placed in a prone position and the laser height 
was positioned roughly 15 cm from a prominent vessel superficial to the gastrocnemius. 







Table 4. Exercise protocol. Mouse concurrent treadmill exercise protocol consisting of a 
“Week 1” acclimation, followed by progressive training “Week 2” and “Week 3”.  Three 
days per week (M,W,F) consisted of endurance-style exercise while two days per week 
































WEEK 1 Monday Tuesday Wednesday Thursday Friday
Warmup 7m/min. for 50m 7m/min. for 50m 7m/min. for 50m 7m/min. for 50m 
Work Rate OFF 7m/min.  8m/min. 9m/min 10m/min.
Rest 3min. off/100m 3min. off/100m 3min. off/100m 3min. off/100m
Distance 300m 300m 300m 300m
WEEK 2 Monday Tuesday-Sprints Wednesday Thursday-Sprints Friday
Warmup 7m/min. for 50m 7m/min. for 50m 7m/min. for 50m 7m/min. for 50m 7m/min. for 50m
Work Rate 11m/min. 15m/min. for 10m 12m/min. 17m/min for 15m 13m/min.
Walk Rate - 7m/min. for 10m - 7m/min. for 15m -
# of Sprints - 8 - 10 -
Rest 3min. off/100m 5mins after 5 sprints 3min. off/100m 5mins after 5 sprints 3min. off/100m
Distance 350m 160m 375m 300m 400m
WEEK 3 Monday Tuesday-Sprints Wednesday Thursday-Sprints Friday
Warmup 7m/min. for 50m 7m/min. for 50m 7m/min. for 50m 7m/min. for 50m 7m/min. for 50m 
Work Rate 13.5m/min. 18m/min. for 15m  14m/min. 20m/min. for 20m 14.5m/min.
Walk Rate - 7m/min. for 15m - 5x-7m/20m; 6x-7m/10m -
# of Sprints - 11 - 11 -
Rest 3min. off/100m 5mins after 5 sprints 3min. off/100m 5mins after 5 sprints 3min. off/100m





Tissue extraction and weight. Both the soleus and gastrocnemius tissues were excised and 
separated from each leg for all experimental groups. Each muscle was washed with 50 
mmol/L phosphate buffer saline (PBS) pH of 7.4, weighed individually, snap frozen in 
liquid nitrogen, and stored at −80°C until use. All tissue extraction methods and timings 
were equated across all groups. 
 
Immunofluorescence . One of each muscle was cut cross-sectionally at the muscle midbelly 
and placed in tissue-freezing medium (Triangle Biomedical Sciences, Durham, NC, USA) 
in disposable plastic tissue-embedding molds (Polysciences Inc., Warrington, PA, USA). 
These tissue blocks were immediately frozen and stored at -80°C until use. Cryosections 
of each muscle, 7-10 µm thick, were obtained using a Cryocut System (CM 1850; Leica 
Microsystems, Buffalo Grove, IL, USA). These tissue sections were placed on Poly-L-
Lysine coated microscope slides (Polysciences, Inc., Warrington, PA, USA) prior to use. 
Slides containing tissue sections were fixated in acetone for 20 mins, washed in 1X PBS-
T solution, and incubated with a permeabilization solution (0.2 g Bovine Serum Albumin, 
3 ul Triton X-100 in 10ml 1X PBS) for 1 hour at RT. This was followed by multiple 
washing steps with 1X PBS-T. The sections were incubated with a primary antibody (anti-
Laminin; Abcam, Cambridge, MA, USA) solution with a dilution of 1:200 overnight at 
4°C. After multiple washing steps with 1X PBS-T, the slides were incubated with a 
fluorescently labeled secondary antibody (goat anti-mouse Alexa flour 594; Invitrogen, 
Waltham, MA, USA) with a 1:300 dilution for 1 hour at RT. This was followed by another 
washing step, then slides were mounted with mounting medium and glass cover slips 





then be visualized using a laser scanning confocal microscope (Olympus Fluo View 1000; 
Center Valley, PA, USA). Cross-sectional area (CSA) measurements were acquired using 
these laminin images by hand tracing single, stained muscle fibers in ImageJ software.  
 
DHE staining for ROS. After tissue excision, each muscle was cross sectioned in half, 
immediately placed in tissue-freezing medium (Triangle Biomedical Sciences, Durham, 
NC, USA), snap frozen and stored at -80°C until use. Samples were sectioned on a cryostat, 
placed on slides, and in situ superoxide generation was evaluated in each cryosection with 
the oxidative fluorescent dye dihydroethidium (DHE). Cryosections (10 μm) were 
incubated with DHE (2 μmol/l) in a PBS solution. After multiple washing steps, slides were 
mounted with mounting medium and a cover slip and allowed to dry. These samples were 
then visualized using a laser scanning confocal microscope (Olympus Fluo View 1000; 
Center Valley, PA, USA).  
 
Protein Extraction and Protein Estimation. Both muscle tissue samples from all groups 
were bead-homogenized in ice‐cold RIPA (1 mmol/L) buffer with PMSF and protease 
inhibitor cocktails (1 μL/mL of lysis buffer, Sigma Aldrich, St. Louis, MO). Centrifugation 
followed with these samples at 12,000 g for 20 min at 4°C. All supernatant was extracted, 
placed in Eppendorf tubes, and immediately stored at −80°C until use. Protein estimation 
of each sample was measured by the Bradford‐dye (Bio‐Rad, CA) method in a 96‐well 
microliter plate compared against a Bovine Serum Albumin (BSA) standards. This plate 







Western Blot Analysis. Protein lysates (40 µg) were prepared and heated at 95°C for 5 min. 
These samples were then loaded into an SDS polyacrylamide gel submerged in running 
buffer and run at a constant current (75 Volts). Proteins were then transferred to a PVDF 
membrane overnight at 120 mA at 4°C. After the transfer, membranes were blocked in 5% 
nonfat milk for 1 hour at room temperature and then incubated overnight with the primary 
antibody (Anti-SOD2; GAPDH;  Abcam, Cambridge, MA, USA.) at 4°C with slow 
agitation. Washing steps occurred the next day with a TBS-T buffer, then membranes were 
incubated with secondary antibody (horse radish peroxidase-conjugated goat anti-rabbit 
IgG, goat anti-mouse; Santa Cruz Biotechnology, Dallas, TX, USA) for 1 hour at RT with 
a 1:5000 dilution followed by another washing step. The membranes were developed using 
an ECL Western blotting detection system (GE Healthcare, Piscataway, NJ, USA) and all 
images were recorded in the gel documentation system ChemiDoc XRS (Bio-Rad, 
Richmond, CA, USA). Membranes, if being re-used, were stripped with stripping buffer 
(Boston BioProducts, Ashland, MA, USA) and blocked with 5% milk for 1 hour at RT 
under agitation. After washing, membranes were incubated with the anti-Gapdh antibody 
(Millipore, Billerica, MA, USA) as a loading control protein. The data were analyzed by 
Bio-Rad Image Lab densitometry software and normalized against anti-Gapdh bands. 
 
Quantitative PCR. In the assessment of mRNA transcripts of specific genes in skeletal 
muscle, RNA was isolated with TRIzol® reagent (Life Technologies, Carlsbad, CA, USA) 
according to the instructions of the manufacturer. The RNA quantification and purity was 





total RNA were reverse-transcribed into cDNA using a High Capacity cDNA Reverse 
Transcription Kit (Applied Biosystems, Foster City, CA) according to the protocol of the 
manufacturer. Quantitative PCR (q-PCR) was performed for different genes (TFAM, 
Myh4, SOD-1, SOD-2), in a final reaction volume of 20 µl containing 10 µl PerfeCTa 
SYBR Green SuperMix, Low ROX (Quanta Biosciences, Gaithersburg, MD), 6 µl 
nuclease free water, 2µl cDNA, 40 picomoles of forward, and reverse primers. The 
information in Table 5 presents all sequence-specific oligonucleotide primers (Invitrogen, 
Carlsbad, CA, USA). The data was represented in fold expression. This was calculated as 
the cycle threshold difference between control and sample normalized with the 
housekeeping genes beta actin and 18s.    
 
Stastical Analysis. All data were expressed as means ± SE. One-way ANOVA analyses 
were conducted on each data set with Tukey’s post-hoc analysis used between groups 
within the same mouse line and the student t-test used between mouse line groups of 
relevance. Significance was determined as a p-value<.05.   
 
Results 
TFAM overexpression reduces atrophic changes. Wet muscle weights were recorded 
immediately after tissue excision. A muscle weight to bodyweight (mg/g) standardization 
ratio was used to account for individual size variation. HLS resulted in non-significant 
decreases of 8.3% in soleus (Fig. 15) and 2.6% in gastrocnemius (Fig. 16) muscle weight 
to bodyweight ratio in mice overexpressing TFAM (T-HLS), compared to TFAM 





























Gene Forward Nucleotide Sequence  Reverse Nucleotide Sequence 
Myh4 
5’- TTGTGGTGGATGCTAAGGAGTC 5’- GTACTTGGGAGGGTTCATGGAG 
SOD-1 5’- GAACCAGTTGTGTTGTCAGGAC 5’- GCCTTGTGTATTGTCCCCATAC 
SOD-2 5’- GGTCACAGTTTCACAGTACACC 5’- TCACAGCCTTGAGTTACAGAGT 
TFAM 
    5’ - GAGAGCTACACTGGGAAACCACA    5’ – CATCAAGGACATCTGAGGAAAA 
Rn18S 
5’- CACGGACAGGATTGACAGATTG 5’- GACAAATCGCTCCACCAACTAA 
ß-actin 
















Figure 15. Soleus weight and CSA. A. Soleus muscle weight to bodyweight ratio (mg/g) 
of wild-type and TFAM transgenic groups (n=6). B. Immunofluorescence images of anti-
laminin staining to visualize muscle fiber size and shape. All pictures are 200 µm in 
width. C. Mean cross-sectional area measurement comparison between groups of anti-
laminin staining images calculated using ImageJ software (n=6). D. Myosin Heavy chain 
4 (Myh4) gene expression analysis of the soleus muscle (n=6). Statistical significance 






































Figure 16. Gastrocnemius weight and CSA. A. Gastrocnemius muscle weight to 
bodyweight ratio (mg/g) of wild-type and TFAM transgenic groups (n=6). B. 
Immunofluorescence images of laminin staining to visualize muscle fiber size and shape. 
All pictures are 200 µm in width. C. Mean cross-sectional area measurement comparison 


































   





decrease in wild-type gastrocnemius in this ratio after HLS, compared to wild-type 
Control TFAM Ex+HLS led to a non-significant increase of 4.5% in the soleus and 
decrease of 0.7% in this ratio in T-HLS, compared to TFAM Control (Fig. 15 and 16). 
Cross-sectional area measurements follow a similar, minor trend with T-HLS tending to 
decrease in both muscles, although with no statistical significance between these groups, 
with T-HLS being significantly greater (Fig. 15 and 16) than wild-type HLS in both 
soleus [805um vs. 668um, p<.01] and gastrocnemius [2085um vs. 1605um, p<.01].  
Moreover, fiber-type transitioning of the soleus muscle was measured through the qPCR 
measurement of Myh4. Here, we see similar levels of Myh4 in both wild-type Ex+HLS 
groups compared to T-Ex+HLS while T-HLS resulted in significantly lower levels of 
Myh4 compared to wild-type HLS (12.89 vs. 7.75, p<.01). 
 
Greater TFAM expression in gastrocnemius. To assess genetic expression of the TFAM 
transgenic model, we completed qPCR analysis of the TFAM transcript across both 
muscles (Fig. 17). Soleus TFAM expression in T-HLS mice was greater than wild-type 
HLS (1.75 vs. .82, p<.01) while T-Control was greater than wild-type Control (2.35 vs. 
1.02, p<.01). In the gastrocnemius, T-HLS was significantly greater than wild-type HLS 
(4.23 vs. .49, p<.01) and T-Control was ~5-fold greater than wild-type Control (5.11 vs. 







Figure 17. TFAM gene expression. A. Soleus TFAM gene expression (n=6). B. 
Gastrocnemius TFAM gene expression. Statistical significance (p<.05) indicated by the 















































Hindlimb bloodflow does not change. Laser Doppler imaging of the left hindlimb 
assessed blood flow through a prominent posterior limb artery superior to the 
gastrocnemius (Fig. 18). Flux is a function of red blood cell (RBC) content and its 
velocity through the vessel of interest. Lack of RBC content to peripheral tissues may 
account for skeletal muscle changes if oxygen and nutrient delivery as well as waste 
removal are impaired. Here we show there were no significant differences in flux 
between all groups (p=.53). 
 
TFAM overexpression increases SOD-1 and SOD-2. Skeletal muscle degradation and 
apoptotic pathways are induced by reactive oxygen species (22, 97). We assessed the 
accumulation of superoxide anion, observationally, through the use of DHE staining. In 
all TFAM transgenic groups, we consistently observed low positive staining markers 
after DHE staining across all groups (Fig. 19). In both soleus and gastrocnemius muscles, 
T-Ex+HLS resulted in minimal positive markers while, interestingly, T-Control and T-
HLS appeared to have dull to low positive staining across multiple observations. 
Superoxide dismutases (SODs) are antioxidant enzymes that catalyze the 
conversion of superoxide anions to hydrogen peroxide (39). Therefore, we measured 
SOD-1 (cytosolic) and SOD-2 (mitochondrial) transcripts via qPCR and SOD-2 protein 
expression via Western blot to assess inter-group antioxidant differences. SOD-1 mRNA 





Figure 18. Hindlimb blood flow. A. Laser Doppler blood flow measurement of a 
prominent vessel in the dorsal hindlimb. B. Blood flux measurement comparison between 







































Figure 19. Soleus and gastrocnemius ROS. A. Observational soleus dihydroethidium 
staining for ROS. Bright spots are assumed to be positive staining for ROS (n=6). B. 
Observational gastrocnemius dihydroethidium staining for ROS. Bright spots are 
































Figure 20. Soleus antioxidants. A. Soleus SOD-1 transcript expression (n=6). B. Soleus 
protein expression via Western blot analysis for antioxidant enzyme SOD-2 (n=6). C. 
Soleus SOD-2 gene transcript expression. Statistical significance (p<.05) indicated by the 






































HLS mice compared to wild-type HLS (P<.05). In the gastrocnemius (Fig. 21), T-Control 
and T-HLS SOD-1 transcripts were both roughly 10-fold greater than wild-type Control 
and HLS (p<.01).  
Transcript analysis of SOD-2 in the soleus (Fig. 20) reveals T-Control being 
~4.5x greater than wild-type Control (p<.01). SOD-2 soleus protein expression was 
greater in T-HLS compared to wild-type HLS (p<.01) as well as T-Control compared to 
wild-type Control (p<.01). After observing gastrocnemius SOD-2 gene expression (Fig. 
21), we see the T-Control group with a nearly 5.5-fold increase compared to Control 
(p<.01) and T-HLS nearly 6-fold greater than HLS (p<.01). Protein expression of this 
antioxidant in the gastrocnemius (Fig. 21) similarly shows increases in both T-HLS and 
T-Control compared to HLS and Control, respectively.   
 
Discussion 
Atrophy of skeletal muscle arises when protein degradation and apoptosis exceeds 
protein synthesis and can occur when the musculature is unloaded or disused (140). 
Previously we have shown evidence of atrophy in both the soleus and gastrocnemius 
skeletal muscle of wild-type mice following a hindlimb-unloading protocol (article in 
submission). This skeletal muscle atrophy is associated with diminished markers of 
mitochondrial biogenesis and function, a reduced antioxidant state, as well as a 







Figure 21. Gastrocnemius antioxidants. A. Gastrocnemius SOD-1 transcript expression 
(n=6). B. Gastrocnemius protein expression via Western blot analysis for antioxidant 
enzyme SOD-2 (n=6). C. Gastrocnemius SOD-2 gene transcript expression (n=6). 






































We successfully reduced atrophy by exercising the musculature prior to hindlimb 
suspension (Table 6), which was associated with improvements in many of these 
mitochondrial and redox markers. Specifically, we observed a trending decrease in 
TFAM gene and protein expression in the soleus and a greater, significant decrease in 
TFAM gene and protein expression in the gastrocnemius muscle after HLS. Therefore, in 
the present study we attempt to more specifically analyze the role of TFAM in muscle 
atrophy using a C57BL/6J-based TFAM overexpression transgenic mouse model in HLS, 
while also observing the effects of combining exercise with this transgenic model.  
Previous research using TFAM transgenic animal models is scarce. A 2005 study 
reported the use of a TFAM transgenic mouse model in a myocardial infarction study and 
results indicate TFAM overexpression ameliorated left-ventricular remodeling, providing 
a cardiomyocyte protective effect (52). Other in vitro studies similarly reveal a 
cardiomyocyte protective role via TFAM overexpression (38, 51). Moreover, 
mitochondrial dysfunction in skeletal muscle atrophy is highly associated with excessive 
ROS. With TFAM protecting mtDNA from ROS as well as increasing mtDNA 
transcription, mtDNA copy number, and mitochondrial biogenesis, we chose to further 
investigate its role in skeletal muscle. 
Initially, we assessed hindlimb blood flow via Doppler laser technology in a 
prominent vessel superior of the gastrocnemius. Blood flow could be a limiting factor in 
muscle atrophy due to decreases in the delivery of oxygen and nutrients and the ability to 
remove waste. There are discrepancies in the literature concerning muscle atrophy related 





Table 6. Bodyweight and muscle weights. Bodyweight (BW) pre-HLS (g) and BW at 
time of sacrifice. Muscle weight of both the soleus and gastrocnemius. All data presented 
as means ± SE.  Statistical significance (p<.05) between groups indicated by the 




































Group   Pre - HLS  
BW   
(g)   
BW   
(g)   
Sol MW   
(mg)   
Gas MW   
(mg)   
Sol  
MW/BW   
(mg/g)   
Gas  
MW/BW   
(mg/g)   
Control   -   24.5 ± .55   7.8 ± .17   121.1 ± 6.10   .32 ± .01   4.9 ± .16   
HLS   23.3 ± .87   22.0 ± .79   5.1 ± .15 a,c,d   85.4 ± 5.5 a,d   .23 ± .01 a,c,f   3.9 ± .24 a,c,f   
Ex+HLS   24.3 ± .78   22.4 ± .67   6.9 ± .33 a,b,d   103.8 ± 4.31   .30 ± .01 d   4.5 ± .07   
Ex   -   23.5 ± .22   7.9 ± .12   110.7 ± 4.30   .34 ±  .003   4.7 ± .15   
T - Ex+HLS   23.8 ± .47   22.9 ± .55   6.8 ± .44   105.2 ± 1.77   .30 ± .03    4.59 ± .14   
T - HLS   26.1 ± .63   23.8 ± .59   6.3 ± .27 b,g   105.9 ± 2.60 b   .261 ± .01 b   4.5 ± .12 b   






However, according to Tyml et al. in a 2001 review of the microvasculature changes in 
disused muscle, this assumption may be incorrect. Multiple animal studies reported here 
on muscle disuse reveal no changes in blood flow in atrophied muscles, indicating no 
changes in mean blood pressure and vascular resistance (145). We similarly observe 
these effects in blood flow with no differences between groups. However, this assessment 
does not specifically analyze capillarization or microvasculature of each muscle, which 
may reveal differences. This limitation in conjunction with the current findings warrants 
future investigation. 
After HLS in transgenic mice we observe muscle wet weight, muscle 
weight/bodyweight ratio, and cross-sectional area are all significantly greater in both the 
soleus and gastrocnemius of the T-HLS group compared to the wild-type HLS group, 
indicating an initial, potential protective role of TFAM overexpression (Fig. 22, Table 6). 
TFAM abundantly binds and protects mtDNA from mitochondrial ROS. As greater 
TFAM comes in contact with mtDNA, greater protection is expected (78). TFAM 
expression is also positively correlated with mtDNA copy number (31). Therefore, results 
from the current study suggest supra-physiologic gene expression of TFAM may lead to, 
speculatively, increased mtDNA protection during an atrophic setting with increased 









Figure 22. Exposed lower hindlimb. Dorsal view of the exposed lower left hindlimb 
with mice, under anesthesia, placed in a prone position. Observational differences 

































In the present study, the transgenic gastrocnemius muscle appears to have a more 
pronounced protective effect from atrophy with minimal reductions in muscle weight, 
size, and shape compared to the greater changes observed in the transgenic soleus. Our 
recent research indicates mitochondrial biogenesis markers, particularly TFAM gene and 
protein expression, in the wild-type gastrocnemius is more affected by 7 days of HLS 
(article in submission). Yajid et al. also report muscle group mitochondrial differences 
where they conclude mitochondrial respiration is most affected in the gastrocnemius after 
HLS in rats. Here the researchers analyzed mitochondrial respiration in 4 separate 
muscles, including the soleus, and noted a 59% decrease in gastrocnemius state 3 
respiration with disuse atrophy (158). The implication is muscle groups with very 
different fiber-type makeups may respond to atrophy differently, and thus should be 
analyzed separately when creating therapeutics. 
Nonetheless, while it appears the gastrocnemius may be more susceptible to 
mitochondrial changes during disuse and potentially able to respond better to 
mitochondrial treatment via the overexpression of the TFAM gene, we must also 
emphasize muscle fiber-type differences between muscle groups. In the analysis of 
C57BL/6J mouse muscle fiber-type composition, the soleus muscle reportedly consists of 
much higher oxidative fibers with 37% type-I fibers and 38% type-IIA fibers while the 
gastrocnemius consisted of much lower oxidative fibers with only ~6% type-I and ~6% 
type-IIA but over 54% type-IIB fibers (2). Oxidative fibers tend to have greater 
mitochondrial content and density while fast-glycolytic fibers tend to have less 
mitochondrial content (88). In speculation, due to the lower volume of mitochondria in 





changes, such as the decreases in TFAM we observe in HLS. By overexpressing this 
highly important gene in mitochondrial health and function that directly protects mtDNA 
copy number and activates mtDNA transcription, it may blunt the gastrocnemius 
sensitivity to mitochondrial fluctuations. While the gastrocnemius in wild-type mice 
revealed a significant decline in TFAM gene and protein expression after HLS, there was 
no significant difference in soleus TFAM gene and protein expression in wild-type mice 
after HLS. The soleus, with greater mitochondrial densities and no significant decreases 
in TFAM, did not benefit from increased TFAM transcript expression to the same extent 
while the gastrocnemius, with significant declines in TFAM after HLS, had the 
physiologic capacity to benefit from overexpression. 
We also observed differences in expression levels between muscles in the 
transgenic mice. To investigate this further, measurements of TFAM mRNA expression 
in transgenic mice against wild-type mice revealed a nearly 2.5-fold increase in 
transgenic soleus TFAM mRNA compared to ~5-fold increase in transgenic 
gastrocnemius TFAM mRNA (Fig. 17). This difference was similar across all transgenic 
treatment groups indicating a potential difference in fiber-type response to the random 
integration of the TFAM transgenic construct. Interestingly, in a study using a PGC-1α 
overexpression mouse model, the authors note the potential for certain promoters to be 
more highly expressed in fast-fibers compared to slow-fibers (14). Although purely 
speculation, this may play a role in the current study to account for expression differences 
between muscle types.  
We previously observed increased superoxide anion after HLS in wild-type mice, 





Cannavino et al. (14). In the present study, we observe much lower expression of ROS 
across both muscles of all transgenic groups compared to wild-type. Also, we see 
increases in SOD-1 gene expression and SOD-2 protein expression of both muscles, with 
the transgenic gastrocnemius revealing more pronounced levels of gene expression of 
both antioxidants compared to the transgenic soleus. These findings are unexpected and 
links TFAM gene overexpression with increased antioxidant status. Interestingly, a 2009 
study isolating mtDNA nucleoids revealed the presence of SOD-2 within each nucleoid, 
potentially acting as a front-line antioxidant defense barrier for mtDNA (72). 
Speculatively, it is possible overexpressing TFAM results in increased mtDNA binding 
and greater nucleoid formation, leading to a higher presence of SOD-2 expression 
antioxidant defense overall. The exact mechanism between these two molecules appears 
to be unknown, to our knowledge, and worthy of future investigation.   
 
Conclusion. Skeletal muscle atrophy is highly correlated with reduced mitochondrial 
biogenesis and function along with excessive ROS leading to the activation of protein 
degradation and apoptotic pathways and the reduction in protein synthesis. Here we 
follow up on our recent research that correlated diminished mitochondrial markers with 
skeletal muscle atrophy and attempt to display a protective role of TFAM in disuse-
induced skeletal muscle atrophy. Moreover, there may be a more pronounced effect in the 
gastrocnemius muscle to TFAM overexpression, which should be considered in future 
research. Our results indicate the overexpression of the TFAM gene is associated with 
increased antioxidant expression as a possible mechanism to prevent catabolic pathway 





manipulate this molecule is an attractive area of research in preventing skeletal muscle 
atrophy. Future research into this molecule could also focus on other tissues and 




























The studies presented in this project were meant to further our knowledge of the 
effect of exercise on skeletal muscle and to attempt to prevent the unwanted effects of 
atrophy during disuse. We reasoned since reductions in markers of mitochondrial 
biogenesis and function as well as redox imbalances were highly correlated with skeletal 
muscle atrophy in numerous research studies, observing and treating this mechanism to 
prevent atrophy may be a useful research endeavor. First, we hypothesized that exercise 
training prior to a disuse-induced atrophic setting would prevent skeletal muscle atrophy. 
Second, we hypothesized that this prevention of atrophy would be associated with 
changes in mitochondrial markers. 
To test our initial hypothesis, we first needed to determine if a 7-day hindlimb 
suspension protocol would induce atrophy and if exercise training prior to this atrophic 
event was linked to atrophy prevention. To test our secondary hypothesis, we had to 
assess the molecular changes associated with this treatment. As discussed in Chapter II, 
HLS results in a 27.1% and 21.5% decrease in soleus and gastrocnemius muscle weight 
to bodyweight ratio in WT mice, respectively, indicating the HLS protocol induced 
atrophy. Exercising prior to HLS resulted in a 5.6% and 8.1% decrease in soleus and 







Exercise increased mitochondrial associated markers (PGC-1α, TFAM, CS, SOD-
2), Slow myosin heavy chain (SMHC) expression, and reduced fiber-type transitioning 
(Myh4). Observationally, Ex+HLS reveals decreased ROS expression compared to HLS. 
Our data indicates the time prior to an atrophic setting, particularly caused by muscle 
unloading, may be a useful period to intervene progressive exercise training to prevent 
skeletal muscle atrophy and is associated with mitochondrial function and redox balance.
Based on the results of Chapter II, we created a third hypothesis that was two-fold 
in which we state TFAM overexpression will prevent skeletal muscle atrophy and 
combining TFAM overexpression with exercise will act synergistically to prevent 
atrophy during HLS. To test this, we had to first obtain a viable C57Bl/6J-based 
transgenic mouse model that positively overexpressed the TFAM gene and subject these 
mice with the same HLS and exercise protocols as the wild-type mice in Chapter II. As 
we see in Chapter III, all transgenic mice were first genotyped to confirm a positive 
overexpression. Overexpressing TFAM results in a decrease of 8.3% in soleus and 2.6% 
in gastrocnemius muscle weight to bodyweight ratio after only HLS compared to wild-
type mice incurring a loss of 27.1% in soleus and 21.5% in gastrocnemius muscle after 
HLS. Our data indicates TFAM may play a critical role in protecting skeletal muscle 
from disuse atrophy and is correlated with increased expression of antioxidants (SOD-2) 
and potential redox balance. Moreover, combining exercise with TFAM overexpression 
had no synergistic effect compared to wild-type Ex+HLS. TFAM may be an attractive 





Combining the results from these studies, the data supports the hypotheses that 
exercise training prior to a disuse-induced atrophy scenario prevents skeletal muscle 
atrophy and this is associated with reductions in markers of mitochondrial biogenesis and 
function. Additionally, TFAM overexpression further results in the prevention of disuse-
induced atrophy while combining exercise with TFAM overexpression appeared to have 
no additional benefit. A mitochondrial mechanism increased by exercise that includes the 
TFAM molecule appears to be an important factor in the prevention of skeletal muscle 
atrophy and in the soleus and gastrocnemius. Refer to Figure 1 for a summary outline. 
 
Exercise and TFAM Protect Skeletal Muscle 
The goal of skeletal muscle atrophy research is ultimately prevention. Preventing 
pathological tissue loss may sustain functional and metabolic activity of the muscle. The 
patient prescribed bedrest after an orthopedic surgery, or any other atrophy scenario, has 
not only a quality of life interest to preserve muscle, but also a financial interest to reduce 
pharmaceutical and rehabilitation costs. The need to study interventions to prevent 
disuse-induced muscle atrophy and the molecular mechanisms associated is warranted to 
create treatments that improve the human condition. 
The molecular processes resulting in atrophy can be viewed more simply as the 
balance of protein degradation and cell apoptosis with protein synthesis. When 
degradation and apoptosis exceed synthesis, a net protein loss occurs and the muscle 
atrophies over time. Any treatment developed to prevent this condition must, in some 





levels of protein synthesis. The main goal of the project was to prevent this imbalance 
with exercise and observe mitochondria variables associated with this prevention as a 
possible mechanism. 
The most prominent findings of this project are: (1) a short-term, concurrent 
exercise training protocol prior to skeletal muscle unloading and disuse diminishes 
skeletal muscle atrophy, (2) atrophy is associated with diminished mitochondrial markers 
of biogenesis and function while exercising prior to disuse is associated with an increase 
in these markers, and (3) the overexpression of the TFAM mitochondrial marker 
diminishes atrophy associated with disuse. Our finding that exercise preconditioning 
diminishes disuse atrophy could lead to changes in instructions to patients prior to 
atrophy-inducing scenarios. In the case of the patient prescribed bedrest post-surgery, the 
overseeing physician may consider prescribing an exercise protocol pre-surgery, if the 
patient status allows, to attempt to prevent the negative consequences of bedrest on 
skeletal muscle. Similarly, an astronaut going into a microgravity environment for a 
shorter period of time could be prescribed exercise training pre-space travel to prevent 
the unloading-induced atrophy typically observed in space flight (150). The findings that 
this prevention is associated with increased mitochondrial markers, and particularly the 
TFAM molecule, is a new area of introspection in skeletal muscle atrophy research. This 
evidence could lead to molecularly directed pharmaceuticals in the future that attempt to 
manipulate the mitochondria and TFAM to sustain mitochondrial biogenesis and function 
pathways and protect mtDNA during muscle disuse and unloading. Further, the finding 
that TFAM overexpression is also potentially linked to increased antioxidant expression 





A more detailed explanation of these findings with the associated results from Chapter II 
and Chapter III is discussed in the following sections. 
 
Exercise preconditioning diminishes skeletal muscle atrophy. A principle finding of this 
project was the reduction of disuse-induce atrophy using an exercise training treatment 
prior to HLS. Our initial physiologic measurement of each group used Doppler laser 
technology to assess blood flow of the lower hindlimb. Changes in blood flow to any 
tissue may influence tissue health due to potential decrements in oxygen and nutrient 
delivery as well as in waste removal. The research in this area is mixed. However, in a 
more specific review of the microvasculature of disuse-induced skeletal muscle atrophy, 
the authors note multiple animal studies reveal no differences in blood flow, mean blood 
pressure, or vascular resistance in atrophied muscle (145). Similarly, we observed no 
significant differences across all groups in blood flow, indicating initially that atrophy 
was not flow-limited. This measurement is a function of RBCs and velocity and was 
observed in a prominent vessel superior to the gastrocnemius in the hindlimb. While there 
were no measurable differences in this vessel, microvasculature measurements may have 
provided useful data in assessing the present results, as we did not account for 
capillarization.  
Prior research using HLS in mice reveal changes in muscle weight, CSA, and 
fiber-type transitioning. Atrophy has been shown to occur in as little as 3 days (14), or 
after 7 or more days of unloading and disuse (56, 66, 116). Here, we similarly observe 
signs of atrophy occurring after 7 days of hindlimb suspension in both the soleus and 





and could be a target for treatment. Furthermore, while changes in nutrition status could 
create variation between groups, bodyweights were recorded prior to and after HLS to 
ensure no drastic reductions occurred while in HLS and food and water consumption was 
monitored daily. In the current project, there were no significant differences in 
bodyweight measurements in this regard. This finding was similar to Ferreira et al. in 
which food intake and bodyweight were both recorded with no significant difference after 
14 days of HLS (36). 
Interventions in the literature to prevent atrophy include electrical stimulation, 
nutrition, and exercise intra- or post-HLS (1, 46, 56, 104, 136). Interventions prior to the 
atrophic setting to improve the atrophic condition are scarce. In Chapter II, we show 
exercise training intervened prior to HLS prevented the loss of muscle weight and size. 
Similarly, a 2016 study using a 4-month swimming protocol prior to immobilizing the 
hindlimb of rats for 5 days in orthosis, which induces atrophy, revealed greater soleus 
muscle weight and size compared to the non-exercise group. Although these treatments 
constructs are very different, the theme of exercise preconditioning prior to disuse was 
similar. 
Fujino et al. measured soleus muscle mass after rats completed 1 session of 
endurance exercise prior to HLS. While the exercise group trended greater in these 
parameters, no significant differences were determined (37). This group also noted 
reductions in MHC I after HLS with the exercise group trending higher but not 
significantly. However, many of these results may be due to the use of a single exercise 
session. A single session may not stress the musculature adequately to induce the 





Furthermore, a single session removes the factor of progressive exercise training. 
Adapting to exercise requires time and can be repetitiously surmounted to achieve, 
incrementally, even greater adaptations. This method is the foundation of progressive 
exercise training (142). Progressive training over time results in these incremental 
increases and greater adaptations and possibly lead to greater skeletal muscle protection. 
However, the translatable nature of a single session may be more useful for human 
adherence. Therefore, we used a concurrent protocol in this study combining moderate 
and more intense exercise over a shorter period (18 days) while still allowing enough 
time for adaptations to surmount. We similarly observed nonsignificant soleus decreases 
after HLS but also report significant decreases of SMHC in the gastrocnemius, revealing 
potential muscle group differences in atrophy susceptibility. This could be due to the 
differences in fiber-type makeup of each muscle and the associated characteristics of each 
fiber type that may make some muscle fibers more prone to atrophy. 
When a muscle is disused, it not only atrophies but the fiber-type makeup will 
also remodel and transition from a slow fiber-type to a fast fiber-type (154). Through the 
measurement of a fast-twitch fiber transitioning marker (Myh4) in the soleus, we found 
when the hindlimbs were exposed to suspension, drastic increases in Myh4 were 
observed indicating a decline in muscle quality occurred. When an exercise treatment 
was intervened prior to suspension, this decline in quality was comparatively reduced, 
indicating improved muscle quality. This is an important measurement to assess muscle 
quality as a function of oxidative ability and resistance to fatigue. The same muscle group 
with increased levels of fast-twitch fiber mRNA tend to be less resistant to fatigue to 





muscle function observed in patients with significant atrophy may be due to this 
decreased resistance to fatigue caused by a remodeled muscle.  
 
Mitochondrial markers are associated with exercise protection. After establishing the 
HLS protocol induces atrophy and an exercise intervention prior to HLS prevented 
atrophy, a molecular analysis of mitochondrial markers was completed. Exercise was 
chosen as a preconditioning treatment to prevent disuse-associated atrophy because of the 
well-known inducing effect it has on mitochondrial biogenesis, particularly PGC-1 α and 
TFAM, and mitochondrial function (61, 87, 119). Our analysis similarly led to the 
important establishment that exercise increased markers of mitochondrial biogenesis and 
function as well as antioxidant expression variably across both muscles.  
In prior research, Liu et al. observed decreased mitochondrial respiration prior to 
the activation of protein degradation pathways in a toxin-induced mouse atrophy model 
(86). Another study observed markers of mitochondrial biogenesis increasing prior to the 
regeneration of muscle after an initial atrophying scenario (28). Therefore, atrophy and 
regeneration seemed to be preceded by changes in mitochondrial function and thus, 
establishing mitochondrial importance with this tissue. In Chapter II, we show decreases 
in markers of the mitochondria after HLS. Decreased mitochondrial biogenesis and 
function markers suggests reductions in overall mitochondrial health. More specifically, a 
reduction in TFAM is highly correlated with reduced mtDNA copy number and 
decreased mitochondrial function (31). Our analysis reveal significant reductions of 





and the literature data, the assumption made in this project is mtDNA copy number and 
function are also diminished by the HLS protocol. This could be associated with the 
reduction of ATP synthesis leading to reduced protein synthesis pathways, and redox 
imbalance leading to the accumulation of ROS and the induction of apoptotic and 
degradation pathways causing an imbalance in the skeletal muscle and a net protein loss 
over the HLS protocol. Notably, most of these markers increased after exercise training 
potentially providing an increased mitochondrial adaptation prior to entering HLS that 
could sustain muscle health over the 7-day atrophying period according to the above 
mechanisms. 
When we examined redox imbalance, we observed increased superoxide anion 
after HLS in both muscles and found SOD-2 expression generally decreased after HLS. 
Similar superoxide anion results were observed by Cannavino et al. after a 7-day HLS 
protocol in mice (14). Here, exercise training increased SOD-2 and links exercise leading 
to greater redox balance. This balance could reduce excessive ROS accumulation that is 
implicated in degradation aspects of skeletal muscle atrophy and may be due to the 
combined factors of increased antioxidant expression and overall greater mitochondrial 
health with exercise training. The combination of increased mitochondrial markers and 
greater redox balance provides the framework for the associated molecular mechanisms 
of exercise protecting skeletal muscle from atrophying during disuse. 
 
TFAM overexpression diminishes skeletal muscle atrophy. Another major finding of this 





transgenic mouse model. This finding is particularly important, as it is the first time, to 
our knowledge, a TFAM overexpression model has been used in the analysis of disuse-
induce skeletal muscle atrophy. We hypothesized this finding based on the evidence in 
the literature that indicated a possible role for TFAM in atrophy. 
Initially, we see results from Kang et al. displaying the idea of a protective effect 
of PGC-1α overexpression on mice skeletal muscle during limb immobilization (66). 
Cannavino et al. similarly show overexpressing PGC-1α in transgenic mice diminished 
skeletal muscle atrophy during hindlimb unloading (14). PGC-1α coactivating with NRF-
1 and NRF-2 initiates the transcription of TFAM from nuclear DNA. Although PGC-1α 
is a diverse protein with many powerful interactions, its role in mitochondrial health 
includes the transcription of the TFAM molecule and is worth isolating in research for 
further study.  
TFAM overexpression research is scarce in pathological scenarios. A 2005 study 
reported the use of a TFAM transgenic mouse model in a myocardial infarction study and 
results indicate TFAM overexpression ameliorated left ventricular remodeling, providing 
a cardiomyocyte protective effect (52). Other in vitro studies similarly reveal a 
cardiomyocyte protective role via TFAM overexpression (38, 51). Reviewing the 
protective effects in cardiac muscle also provides evidence for a potential use in skeletal 
muscle, even though there are differences between the tissues. From a redox balance 
standpoint, mitochondrial dysfunction is highly correlated with excessive ROS and is a 
variable that should be considered when attempting to improve muscle health. As 
previous research has already shown, TFAM protects mtDNA from degradation via ROS 





mitochondrial biogenesis. This data provides evidence that the overexpression of this 
molecule can prevent atrophy, as atrophy is correlated to diminished mitochondrial 
factors. In Chapter II we found decreases in TFAM after the HLS protocol. Based on this 
finding, in Chapter III we tested TFAM overexpression in HLS which led to greater 
skeletal muscle weight to bodyweight ratios and CSA of muscle fibers and echoed our 
hypothesis that TFAM would improve this condition. Increased TFAM transcripts may 
have led to increased TFAM protein translation and import into the mitochondria. 
Assumingly, this protein could interact with mtDNA and protect it from the excessive 
ROS that accrues during HLS and increase or sustain mitochondrial biogenesis and 
function by activating transcription of mtDNA and retaining mitochondrial function with 
subsequent ATP synthesis and redox balance. As discussed previously, these aspects of 
are of key importance in protein degradation, apoptosis, and protein synthesis in skeletal 
muscle. 
Kang’s group, in the analysis of skeletal muscle using a PGC-1α overexpression 
mouse transgenic model after limb immobilization-remobilization, note decreased 
superoxide and increased SOD-2 expression in the transgenic mouse model (66). This 
positive correlation between PGC-1α and antioxidants has also been shown previously in 
skeletal muscle (67). In Chapter II, we observe increased antioxidant status across both 
muscles in all TFAM transgenic groups, including controls. This observation is important 
because the above research on PGC-1α link the increase in antioxidants to mechanisms 
preceding or outside of TFAM. Here we are linking increased antioxidants specifically to 
TFAM overexpression while data in the literature on this connection is scarce. However, 





nucleoid, potentially acting as a front-line antioxidant defense barrier for mtDNA (72). 
Speculatively, it could be overexpressing TFAM results in increased mtDNA-TFAM 
protein interaction and greater nucleoid formation, leading to greater SOD-2 expression 
within these nucleoids. A specific mechanism here, however, appears to be unknown and 
worth investigation. Through increased TFAM overexpression and increased antioxidant 
expression, the typical inducer of protein degradation and mitochondrial based apoptotic 
pathways (i.e. ROS) could be neutralized during muscle disuse. Many of the major 
molecular degradation factors leading to muscle atrophy are therefore prevented or 
diminished and could account for the positive effects of TFAM overexpression 
preventing skeletal muscle atrophy. Indeed, here we observed diminished ROS 
accumulation in the form of superoxide anion across all TFAM groups as observational 
evidence of this potential mechanism. 
Another point of emphasis in this project was to compare the results of two 
separate muscles with very different fiber-type makeups in the soleus and gastrocnemius. 
While both muscles appeared to atrophy in wild-type mice after HLS, TFAM 
overexpression mice were both significantly greater than wild-type HLS. The 
gastrocnemius responded, potentially, to a greater extent to TFAM overexpression 
compared to the soleus. TFAM HLS gastrocnemius muscle weight to body weight ratio 
was nearly identical to TFAM Control, with CSA and immunofluorescence imaging of 
the muscle fibers revealing similar results. In Chapter II, we show a significant decrease 
in TFAM in the gastrocnemius and not in the soleus after HLS. These results combined 
with the more robust response of the gastrocnemius to TFAM overexpression may 





better responder to TFAM overexpression. We also observed greater TFAM mRNA 
levels in the gastrocnemius compared to the soleus in transgenic groups. The 
gastrocnemius, with a greater fast-twitch fiber makeup, may also be more receptive to the 
random integration of the TFAM transgenic construct. In the Cannavino et al. study, the 
authors note the potential for certain promoters to be more highly expressed in fast-fibers 
compared to slow-fibers (14). Speculatively, this may account for expression differences 
between muscle types. 
A final finding of this project is that combining exercise training with TFAM 
overexpression resulted in no synergistic effects in diminishing skeletal muscle atrophy. 
One could assume, due to the diverse signaling response to exercise, adding an exercise 
treatment to TFAM overexpression would further prevent muscle atrophy. Here, in most 
measures, TFAM Ex+HLS was not significantly different when compared to wild-type 
Ex+HLS, which countered our proposed hypothesis. This could be due to possible 
physiological limitations in available mRNA and messaging pathways leading to 
mitochondrial protection. With the TFAM gene already being overexpressed in 
transgenic mice, adding in mitochondrial biogenesis signals in the form of exercise may 
not have been able to further affect this process. Due to these observations we conclude 
this combination of treatments was not superior to either treatment alone.  
 
Future Directions 
We have demonstrated through the results of this project that exercise training 





is associated with changes in particular mitochondrial markers, most notably TFAM, 
which can be manipulated to also play a protective role. However, the acquisition of new 
knowledge brings forth the attainment of new questions, which we find to be the same 
here. For example, what changes occur to the markers of degradation and synthesis 
during HLS? Two prominent degradation molecules and E3 ubiquitin ligases, muscle 
RING finger-1 (Murf-1) and muscle atrophy F-Box (MAFbx)/Atrogin-1, have been 
shown to be transcriptionally increased during skeletal muscle atrophy in over 10 years of 
research (11). While multiple studies mentioned previously have linked mitochondrial 
dysfunction and ROS to these degradation markers, future research into a comprehensive 
connection of degradation and apoptotic markers to the treatments in this project and 
atrophy prevention is warranted. Did exercise prior to HLS reduce degradation 
molecules? Did TFAM overexpression reduce pathways to cell apoptosis? These 
questions could build upon our molecular understanding of the current research. 
While previously mentioned research linked decreases in protein synthesis 
pathways to mitochondrial dysfunction and ROS, direct measurement of these pathways 
was not conducted in the present study. A useful study design could be the analysis of the 
Akt/mTOR pathway in conjunction with TFAM overexpression and exercise treatments. 
Particularly in exercise, a known inducer of mTOR (71), a protein synthesis analysis 
study could provide useful data. Furthermore, different types of exercise could be studied 
to observe any superiority in training styles. For example, while resistance training 
appears to activate protein synthesis greater than other forms of exercise, will this type of 
exercise alone or in conjunction with other forms or exercise provide superior results due 





Another potential area to explore based off the current data derived from this 
project is a deeper mitochondrial analysis. While many of the markers measured here 
have been thoroughly linked to mitochondrial dysfunction, a specific functional study 
analyzing mtDNA, respiration markers, O2 consumption and ATP synthesis rates, and 
possibly transmission electron microscopy to visualize mitochondrial size and number 
would be useful to explore. Similarly, while our ROS measurements matched previous 
research in HLS, an in-depth analysis of ROS using multiple measurement techniques 
during skeletal muscle atrophy and the associated mitochondrial effects could also be 
another useful endeavor to elucidate ROS in atrophy. 
Due to the results of TFAM overexpression, pharmaceutical and therapeutic 
options that are TFAM-directed may be useful to study. If TFAM transcription can be 
pharmacologically stimulated or if the role of TFAM can be pharmacologically 
replicated, a medicinal intervention could be synthesized. Provided greater basic research 
is needed, the use of a medicinal intervention to protect mtDNA and potentially 
mitochondrial function during scenarios of skeletal muscle disuse could reduce healthcare 
costs and improve the quality of lives of numerous patients every year. Translationally, a 
project using human subjects choosing elective surgery that will be prescribed bedrest 
post-surgery could be directed into an exercise protocol prior to going into surgery. This 
could translate the results of our basic research and is an obvious next step that we 
believe should be undertaken. 
Collectively, the results of this project provide useful data into the prevention of 





it is my sincerest hope this information will be used to build upon viable treatment 
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